MXPA06008976A - Tooth coating compositions and methods - Google Patents
Tooth coating compositions and methodsInfo
- Publication number
- MXPA06008976A MXPA06008976A MXPA/A/2006/008976A MXPA06008976A MXPA06008976A MX PA06008976 A MXPA06008976 A MX PA06008976A MX PA06008976 A MXPA06008976 A MX PA06008976A MX PA06008976 A MXPA06008976 A MX PA06008976A
- Authority
- MX
- Mexico
- Prior art keywords
- tooth
- coating
- clause
- natural
- oxide
- Prior art date
Links
- 239000008199 coating composition Substances 0.000 title claims description 15
- 239000000025 natural resin Substances 0.000 claims abstract description 62
- 239000011248 coating agent Substances 0.000 claims abstract description 58
- 238000000576 coating method Methods 0.000 claims abstract description 58
- 239000002245 particle Substances 0.000 claims abstract description 42
- 239000003086 colorant Substances 0.000 claims abstract description 29
- 238000004040 coloring Methods 0.000 claims abstract description 9
- 210000000515 Tooth Anatomy 0.000 claims description 138
- 239000000203 mixture Substances 0.000 claims description 113
- -1 acroids Substances 0.000 claims description 53
- 239000012530 fluid Substances 0.000 claims description 38
- 239000011347 resin Substances 0.000 claims description 35
- 229920005989 resin Polymers 0.000 claims description 35
- 239000003795 chemical substances by application Substances 0.000 claims description 21
- 229910052618 mica group Inorganic materials 0.000 claims description 20
- 239000010445 mica Substances 0.000 claims description 19
- 229920000642 polymer Polymers 0.000 claims description 18
- KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 claims description 17
- 229920001800 Shellac Polymers 0.000 claims description 15
- 229920000058 polyacrylate Polymers 0.000 claims description 15
- 239000004208 shellac Substances 0.000 claims description 15
- 235000013874 shellac Nutrition 0.000 claims description 15
- 229940113147 shellac Drugs 0.000 claims description 15
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 15
- 229920002401 polyacrylamide Polymers 0.000 claims description 11
- 239000002253 acid Substances 0.000 claims description 10
- OGIDPMRJRNCKJF-UHFFFAOYSA-N TiO Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 claims description 9
- 239000004922 lacquer Substances 0.000 claims description 9
- 229910001929 titanium oxide Inorganic materials 0.000 claims description 9
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium monoxide Chemical compound [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 claims description 8
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Chemical compound [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 claims description 8
- 239000011149 active material Substances 0.000 claims description 7
- 239000003921 oil Substances 0.000 claims description 7
- RTAQQCXQSZGOHL-UHFFFAOYSA-N titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 claims description 7
- 239000010936 titanium Substances 0.000 claims description 7
- 229910052719 titanium Inorganic materials 0.000 claims description 7
- 239000004698 Polyethylene (PE) Substances 0.000 claims description 6
- 229920001577 copolymer Polymers 0.000 claims description 6
- 229910044991 metal oxide Inorganic materials 0.000 claims description 6
- 150000004706 metal oxides Chemical class 0.000 claims description 6
- 229920000573 polyethylene Polymers 0.000 claims description 6
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 6
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 6
- 239000003975 dentin desensitizing agent Substances 0.000 claims description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 5
- 241000238631 Hexapoda Species 0.000 claims description 4
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims description 4
- XOLBLPGZBRYERU-UHFFFAOYSA-N Tin dioxide Chemical compound O=[Sn]=O XOLBLPGZBRYERU-UHFFFAOYSA-N 0.000 claims description 4
- 239000002260 anti-inflammatory agent Substances 0.000 claims description 4
- 239000004599 antimicrobial Substances 0.000 claims description 4
- 239000003963 antioxidant agent Substances 0.000 claims description 4
- 235000006708 antioxidants Nutrition 0.000 claims description 4
- 239000008376 breath freshener Substances 0.000 claims description 4
- 239000000292 calcium oxide Substances 0.000 claims description 4
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims description 4
- 239000000395 magnesium oxide Substances 0.000 claims description 4
- 239000004854 plant resin Substances 0.000 claims description 4
- 229910001887 tin oxide Inorganic materials 0.000 claims description 4
- 235000007173 Abies balsamea Nutrition 0.000 claims description 3
- 241000251468 Actinopterygii Species 0.000 claims description 3
- GLQBXSIPUULYOG-UHFFFAOYSA-M Bismuth oxychloride Chemical compound Cl[Bi]=O GLQBXSIPUULYOG-UHFFFAOYSA-M 0.000 claims description 3
- 241001608519 Bursera fagaroides Species 0.000 claims description 3
- 240000005209 Canarium indicum Species 0.000 claims description 3
- 239000004859 Copal Substances 0.000 claims description 3
- 239000005751 Copper oxide Substances 0.000 claims description 3
- 235000015912 Impatiens biflora Nutrition 0.000 claims description 3
- 241000237852 Mollusca Species 0.000 claims description 3
- 241000736873 Tetraclinis articulata Species 0.000 claims description 3
- PNEYBMLMFCGWSK-UHFFFAOYSA-N al2o3 Chemical compound [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 claims description 3
- 230000003110 anti-inflammatory Effects 0.000 claims description 3
- 230000002882 anti-plaque Effects 0.000 claims description 3
- 229940073609 bismuth oxychloride Drugs 0.000 claims description 3
- 239000007844 bleaching agent Substances 0.000 claims description 3
- 150000001875 compounds Chemical class 0.000 claims description 3
- QPLDLSVMHZLSFG-UHFFFAOYSA-N copper oxide Chemical compound [Cu]=O QPLDLSVMHZLSFG-UHFFFAOYSA-N 0.000 claims description 3
- 229910000431 copper oxide Inorganic materials 0.000 claims description 3
- 239000004862 elemi Substances 0.000 claims description 3
- 235000013305 food Nutrition 0.000 claims description 3
- 235000012738 indigotine Nutrition 0.000 claims description 3
- 239000004179 indigotine Substances 0.000 claims description 3
- 229910000460 iron oxide Inorganic materials 0.000 claims description 3
- 235000015097 nutrients Nutrition 0.000 claims description 3
- 239000011022 opal Substances 0.000 claims description 3
- 229920001223 polyethylene glycol Polymers 0.000 claims description 3
- IZMJMCDDWKSTTK-UHFFFAOYSA-N quinoline yellow Chemical compound C1=CC=CC2=NC(C3C(C4=CC=CC=C4C3=O)=O)=CC=C21 IZMJMCDDWKSTTK-UHFFFAOYSA-N 0.000 claims description 3
- BPQQTUXANYXVAA-UHFFFAOYSA-N silicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 claims description 3
- 239000004408 titanium dioxide Substances 0.000 claims description 3
- 229910052725 zinc Inorganic materials 0.000 claims description 3
- 239000011701 zinc Substances 0.000 claims description 3
- 240000000972 Agathis dammara Species 0.000 claims description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 2
- 229920002871 Dammar gum Polymers 0.000 claims description 2
- 229940051147 FD&C yellow no. 6 Drugs 0.000 claims description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims description 2
- IEQIEDJGQAUEQZ-UHFFFAOYSA-N Phthalocyanine Chemical compound N1C(N=C2C3=CC=CC=C3C(N=C3C4=CC=CC=C4C(=N4)N3)=N2)=C(C=CC=C2)C2=C1N=C1C2=CC=CC=C2C4=N1 IEQIEDJGQAUEQZ-UHFFFAOYSA-N 0.000 claims description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 2
- 239000004793 Polystyrene Substances 0.000 claims description 2
- 150000007513 acids Chemical class 0.000 claims description 2
- 229910052782 aluminium Inorganic materials 0.000 claims description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminum Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 2
- 230000000845 anti-microbial Effects 0.000 claims description 2
- 230000000111 anti-oxidant Effects 0.000 claims description 2
- 125000000751 azo group Chemical group [*]N=N[*] 0.000 claims description 2
- 229920001400 block copolymer Polymers 0.000 claims description 2
- 235000012745 brilliant blue FCF Nutrition 0.000 claims description 2
- 239000004161 brilliant blue FCF Substances 0.000 claims description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 2
- 239000004075 cariostatic agent Substances 0.000 claims description 2
- 235000019240 fast green FCF Nutrition 0.000 claims description 2
- 229920000578 graft polymer Polymers 0.000 claims description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims description 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 2
- 229920000609 methyl cellulose Polymers 0.000 claims description 2
- 235000010981 methylcellulose Nutrition 0.000 claims description 2
- 229920002223 polystyrene Polymers 0.000 claims description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 2
- 159000000000 sodium salts Chemical class 0.000 claims description 2
- 235000013799 ultramarine blue Nutrition 0.000 claims description 2
- 239000002966 varnish Substances 0.000 claims description 2
- 229940075484 D&C red no. 30 Drugs 0.000 claims 2
- 244000018716 Impatiens biflora Species 0.000 claims 2
- JEIPFZHSYJVQDO-UHFFFAOYSA-N Iron(III) oxide Chemical compound O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 claims 2
- 235000017276 Salvia Nutrition 0.000 claims 2
- 240000007164 Salvia officinalis Species 0.000 claims 2
- 229910000423 chromium oxide Inorganic materials 0.000 claims 2
- 239000011049 pearl Substances 0.000 claims 2
- 229920001343 polytetrafluoroethylene Polymers 0.000 claims 2
- 239000004810 polytetrafluoroethylene Substances 0.000 claims 2
- 239000000377 silicon dioxide Substances 0.000 claims 2
- WGLPBDUCMAPZCE-UHFFFAOYSA-N trioxochromium Chemical compound O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 claims 2
- 229940011411 Erythrosine Drugs 0.000 claims 1
- 230000002272 anti-calculus Effects 0.000 claims 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N disodium Chemical class [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 claims 1
- POXPUHKJGLHZEM-DJOSVPKASA-L disodium;(5Z)-5-[(2-methoxy-5-methyl-4-sulfonatophenyl)hydrazinylidene]-6-oxonaphthalene-2-sulfonate Chemical compound [Na+].[Na+].COC1=CC(S([O-])(=O)=O)=C(C)C=C1N\N=C/1C2=CC=C(S([O-])(=O)=O)C=C2C=CC\1=O POXPUHKJGLHZEM-DJOSVPKASA-L 0.000 claims 1
- 235000012732 erythrosine Nutrition 0.000 claims 1
- 239000004174 erythrosine Substances 0.000 claims 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N glycol Chemical group OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 claims 1
- UJMBCXLDXJUMFB-UHFFFAOYSA-K trisodium;5-oxo-1-(4-sulfonatophenyl)-4-[(4-sulfonatophenyl)diazenyl]-4H-pyrazole-3-carboxylate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(=O)C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 UJMBCXLDXJUMFB-UHFFFAOYSA-K 0.000 claims 1
- 239000000975 dye Substances 0.000 description 20
- 239000000463 material Substances 0.000 description 19
- 239000000049 pigment Substances 0.000 description 19
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 14
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 11
- FQPSGWSUVKBHSU-UHFFFAOYSA-N Methacrylamide Chemical compound CC(=C)C(N)=O FQPSGWSUVKBHSU-UHFFFAOYSA-N 0.000 description 10
- 210000000214 Mouth Anatomy 0.000 description 9
- 239000000796 flavoring agent Substances 0.000 description 9
- 239000003242 anti bacterial agent Substances 0.000 description 8
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 8
- 229910052737 gold Inorganic materials 0.000 description 8
- 239000010931 gold Substances 0.000 description 8
- 239000002904 solvent Substances 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 229920001059 synthetic polymer Polymers 0.000 description 8
- 235000019634 flavors Nutrition 0.000 description 7
- 235000003599 food sweetener Nutrition 0.000 description 7
- 238000009472 formulation Methods 0.000 description 7
- 239000007787 solid Substances 0.000 description 7
- 239000003765 sweetening agent Substances 0.000 description 7
- 229940068196 placebo Drugs 0.000 description 6
- 239000000902 placebo Substances 0.000 description 6
- 150000003839 salts Chemical group 0.000 description 6
- 239000011780 sodium chloride Substances 0.000 description 6
- 235000002639 sodium chloride Nutrition 0.000 description 6
- XLOMVQKBTHCTTD-UHFFFAOYSA-N zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 6
- HRPVXLWXLXDGHG-UHFFFAOYSA-N acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 235000019198 oils Nutrition 0.000 description 5
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 5
- 210000003298 Dental Enamel Anatomy 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- CGIGDMFJXJATDK-UHFFFAOYSA-N Indometacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 4
- 241000124008 Mammalia Species 0.000 description 4
- 240000005428 Pistacia lentiscus Species 0.000 description 4
- 239000000853 adhesive Substances 0.000 description 4
- 230000001070 adhesive Effects 0.000 description 4
- 125000002723 alicyclic group Chemical group 0.000 description 4
- 238000004061 bleaching Methods 0.000 description 4
- RYGMFSIKBFXOCR-UHFFFAOYSA-N copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 4
- 229910052802 copper Inorganic materials 0.000 description 4
- 239000010949 copper Substances 0.000 description 4
- 239000002537 cosmetic Substances 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 125000000623 heterocyclic group Chemical group 0.000 description 4
- 230000002209 hydrophobic Effects 0.000 description 4
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 229910052751 metal Inorganic materials 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- 235000010755 mineral Nutrition 0.000 description 4
- 239000011707 mineral Substances 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 238000006011 modification reaction Methods 0.000 description 4
- 239000000178 monomer Substances 0.000 description 4
- 229920000193 polymethacrylate Polymers 0.000 description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
- 239000012463 white pigment Substances 0.000 description 4
- 230000002087 whitening Effects 0.000 description 4
- PTFCDOFLOPIGGS-UHFFFAOYSA-N zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 description 4
- KOYYEPZTIWTHDY-UHFFFAOYSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;zinc;dihydrate Chemical compound O.O.[Zn].[Zn].[Zn].OC(=O)CC(O)(C(O)=O)CC(O)=O.OC(=O)CC(O)(C(O)=O)CC(O)=O KOYYEPZTIWTHDY-UHFFFAOYSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- XAPRFLSJBSXESP-UHFFFAOYSA-N Oxycinchophen Chemical compound N=1C2=CC=CC=C2C(C(=O)O)=C(O)C=1C1=CC=CC=C1 XAPRFLSJBSXESP-UHFFFAOYSA-N 0.000 description 3
- 210000003296 Saliva Anatomy 0.000 description 3
- 229940068475 ZINC CITRATE Drugs 0.000 description 3
- 229960000306 Zinc Gluconate Drugs 0.000 description 3
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 description 3
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000001023 inorganic pigment Substances 0.000 description 3
- 150000002734 metacrylic acid derivatives Chemical class 0.000 description 3
- CERQOIWHTDAKMF-UHFFFAOYSA-M methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 3
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 3
- 239000012188 paraffin wax Substances 0.000 description 3
- 150000002978 peroxides Chemical class 0.000 description 3
- 229920001888 polyacrylic acid Polymers 0.000 description 3
- 238000006116 polymerization reaction Methods 0.000 description 3
- BQCADISMDOOEFD-UHFFFAOYSA-N silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 3
- 229910052709 silver Inorganic materials 0.000 description 3
- 239000004332 silver Substances 0.000 description 3
- 239000011746 zinc citrate Substances 0.000 description 3
- 235000006076 zinc citrate Nutrition 0.000 description 3
- 239000011670 zinc gluconate Substances 0.000 description 3
- 235000011478 zinc gluconate Nutrition 0.000 description 3
- 239000011787 zinc oxide Substances 0.000 description 3
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 2
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 description 2
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 2
- WEEGYLXZBRQIMU-WAAGHKOSSA-N 1,8-cineol Chemical compound C1C[C@H]2CC[C@]1(C)OC2(C)C WEEGYLXZBRQIMU-WAAGHKOSSA-N 0.000 description 2
- WEEGYLXZBRQIMU-UHFFFAOYSA-N 1,8-cineole Natural products C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 2
- 229940116904 ANTIINFLAMMATORY THERAPEUTIC RADIOPHARMACEUTICALS Drugs 0.000 description 2
- HUMNYLRZRPPJDN-UHFFFAOYSA-N Benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 2
- 229940095259 Butylated Hydroxytoluene Drugs 0.000 description 2
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 2
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 2
- 229940095618 Calcium Glycerophosphate Drugs 0.000 description 2
- UHHRFSOMMCWGSO-UHFFFAOYSA-L Calcium glycerylphosphate Chemical compound [Ca+2].OCC(CO)OP([O-])([O-])=O UHHRFSOMMCWGSO-UHFFFAOYSA-L 0.000 description 2
- 239000001736 Calcium glycerylphosphate Substances 0.000 description 2
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L Calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 description 2
- 229960003260 Chlorhexidine Drugs 0.000 description 2
- OROGSEYTTFOCAN-DNJOTXNNSA-N Codeine Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC OROGSEYTTFOCAN-DNJOTXNNSA-N 0.000 description 2
- ORTQZVOHEJQUHG-UHFFFAOYSA-L Copper(II) chloride Chemical compound Cl[Cu]Cl ORTQZVOHEJQUHG-UHFFFAOYSA-L 0.000 description 2
- 229920001651 Cyanoacrylate Polymers 0.000 description 2
- USIUVYZYUHIAEV-UHFFFAOYSA-N Diphenyl ether Chemical class C=1C=CC=CC=1OC1=CC=CC=C1 USIUVYZYUHIAEV-UHFFFAOYSA-N 0.000 description 2
- 108010015776 EC 1.1.3.4 Proteins 0.000 description 2
- 229940109501 Eucalyptol Drugs 0.000 description 2
- 229940044949 Eucalyptus oil Drugs 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N Eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Exidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 2
- 229960002737 Fructose Drugs 0.000 description 2
- 229940116332 GLUCOSE OXIDASE Drugs 0.000 description 2
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 2
- 239000004366 Glucose oxidase Substances 0.000 description 2
- WQYVRQLZKVEZGA-UHFFFAOYSA-N Hypochlorite Chemical compound Cl[O-] WQYVRQLZKVEZGA-UHFFFAOYSA-N 0.000 description 2
- 229940021015 I.V. solution additive Amino Acids Drugs 0.000 description 2
- 229960000905 Indomethacin Drugs 0.000 description 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 2
- 229960004873 LEVOMENTHOL Drugs 0.000 description 2
- OYHQOLUKZRVURQ-IXWMQOLASA-N Linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 2
- 102100008175 MGAM Human genes 0.000 description 2
- GUBGYTABKSRVRQ-YOLKTULGSA-N Maltose Natural products O([C@@H]1[C@H](O)[C@@H](O)[C@H](O)O[C@H]1CO)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 GUBGYTABKSRVRQ-YOLKTULGSA-N 0.000 description 2
- 229940041616 Menthol Drugs 0.000 description 2
- XHXUANMFYXWVNG-ADEWGFFLSA-N Menthyl acetate Natural products CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(C)=O XHXUANMFYXWVNG-ADEWGFFLSA-N 0.000 description 2
- MWCLLHOVUTZFKS-UHFFFAOYSA-N Methyl 2-cyanoacrylate Chemical compound COC(=O)C(=C)C#N MWCLLHOVUTZFKS-UHFFFAOYSA-N 0.000 description 2
- OSWPMRLSEDHDFF-UHFFFAOYSA-N Methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 2
- 229940074726 OPHTHALMOLOGIC ANTIINFLAMMATORY AGENTS Drugs 0.000 description 2
- 108090000854 Oxidoreductases Proteins 0.000 description 2
- 102000004316 Oxidoreductases Human genes 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Natural products OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 229920000388 Polyphosphate Polymers 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N Potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 2
- SMTZFNFIKUPEJC-UHFFFAOYSA-N Roxatidine Chemical compound CC(=O)OCC(=O)NCCCOC1=CC=CC(CN2CCCCC2)=C1 SMTZFNFIKUPEJC-UHFFFAOYSA-N 0.000 description 2
- CVHZOJJKTDOEJC-UHFFFAOYSA-N Saccharin Chemical class C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 2
- INVGWHRKADIJHF-UHFFFAOYSA-N Sanguinarin Chemical compound C1=C2OCOC2=CC2=C3[N+](C)=CC4=C(OCO5)C5=CC=C4C3=CC=C21 INVGWHRKADIJHF-UHFFFAOYSA-N 0.000 description 2
- VWDWKYIASSYTQR-UHFFFAOYSA-N Sodium nitrate Chemical group [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 229940032147 Starch Drugs 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N Trimethylglycine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- 229940045136 Urea Drugs 0.000 description 2
- 229940029983 VITAMINS Drugs 0.000 description 2
- MWOOGOJBHIARFG-UHFFFAOYSA-N Vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 2
- 229940021016 Vitamin IV solution additives Drugs 0.000 description 2
- SRBFZHDQGSBBOR-SQOUGZDYSA-N Xylose Natural products O[C@@H]1CO[C@@H](O)[C@@H](O)[C@@H]1O SRBFZHDQGSBBOR-SQOUGZDYSA-N 0.000 description 2
- 241000209149 Zea Species 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 229960000314 Zinc Acetate Drugs 0.000 description 2
- 229960001296 Zinc Oxide Drugs 0.000 description 2
- DJWUNCQRNNEAKC-UHFFFAOYSA-L Zinc acetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O DJWUNCQRNNEAKC-UHFFFAOYSA-L 0.000 description 2
- NWONKYPBYAMBJT-UHFFFAOYSA-L Zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 2
- 229960001138 acetylsalicylic acid Drugs 0.000 description 2
- 150000003926 acrylamides Chemical class 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000001464 adherent Effects 0.000 description 2
- 125000003545 alkoxy group Chemical group 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000000202 analgesic Effects 0.000 description 2
- 230000003078 antioxidant Effects 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 230000001680 brushing Effects 0.000 description 2
- RICLFGYGYQXUFH-UHFFFAOYSA-N buspirone hydrochloride Chemical compound [H+].[Cl-].C1C(=O)N(CCCCN2CCN(CC2)C=2N=CC=CN=2)C(=O)CC21CCCC2 RICLFGYGYQXUFH-UHFFFAOYSA-N 0.000 description 2
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 235000019299 calcium glycerylphosphate Nutrition 0.000 description 2
- 239000001527 calcium lactate Substances 0.000 description 2
- 235000011086 calcium lactate Nutrition 0.000 description 2
- 229960002401 calcium lactate Drugs 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 229960000539 carbamide Drugs 0.000 description 2
- 235000013877 carbamide Nutrition 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- QBWCMBCROVPCKQ-UHFFFAOYSA-M chlorite Chemical compound [O-]Cl=O QBWCMBCROVPCKQ-UHFFFAOYSA-M 0.000 description 2
- 229910001919 chlorite Inorganic materials 0.000 description 2
- 229910052619 chlorite group Inorganic materials 0.000 description 2
- 229960005233 cineole Drugs 0.000 description 2
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N cinnamic aldehyde Natural products O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 238000007334 copolymerization reaction Methods 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 235000005824 corn Nutrition 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drugs Drugs 0.000 description 2
- 239000010642 eucalyptus oil Substances 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 235000019420 glucose oxidase Nutrition 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 235000013615 non-nutritive sweetener Nutrition 0.000 description 2
- 230000003287 optical Effects 0.000 description 2
- 150000002989 phenols Chemical class 0.000 description 2
- 239000004584 polyacrylic acid Substances 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 239000001205 polyphosphate Substances 0.000 description 2
- 235000011176 polyphosphates Nutrition 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 230000001376 precipitating Effects 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 239000003638 reducing agent Substances 0.000 description 2
- 239000011775 sodium fluoride Substances 0.000 description 2
- 235000013024 sodium fluoride Nutrition 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 2
- 229910052712 strontium Inorganic materials 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 230000002194 synthesizing Effects 0.000 description 2
- 239000000057 synthetic resin Substances 0.000 description 2
- 229920003002 synthetic resin Polymers 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 230000001225 therapeutic Effects 0.000 description 2
- 150000003568 thioethers Chemical class 0.000 description 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 2
- 125000002348 vinylic group Chemical group 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229930003231 vitamins Natural products 0.000 description 2
- 229920003176 water-insoluble polymer Polymers 0.000 description 2
- 239000004246 zinc acetate Substances 0.000 description 2
- 235000013904 zinc acetate Nutrition 0.000 description 2
- 229940071566 zinc glycinate Drugs 0.000 description 2
- 229910000368 zinc sulfate Inorganic materials 0.000 description 2
- 229960001763 zinc sulfate Drugs 0.000 description 2
- UOXSXMSTSYWNMH-UHFFFAOYSA-L zinc;2-aminoacetate Chemical compound [Zn+2].NCC([O-])=O.NCC([O-])=O UOXSXMSTSYWNMH-UHFFFAOYSA-L 0.000 description 2
- BAQAVOSOZGMPRM-JVFSCRHWSA-N (2R,3R,4R,5R,6R)-2-[(2S,3R,4R,5R)-2,5-bis(chloromethyl)-3,4-dihydroxyoxolan-2-yl]oxy-5-chloro-6-(hydroxymethyl)oxane-3,4-diol Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@]1(CCl)[C@H](O)[C@@H](O)[C@H](CCl)O1 BAQAVOSOZGMPRM-JVFSCRHWSA-N 0.000 description 1
- QJVHTELASVOWBE-AGNWQMPPSA-N (2S,5R,6R)-6-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid;(2R,3Z,5R)-3-(2-hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptane-2-carboxylic acid Chemical compound OC(=O)[C@H]1C(=C/CO)/O[C@@H]2CC(=O)N21.C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 QJVHTELASVOWBE-AGNWQMPPSA-N 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- 239000001605 (5-methyl-2-propan-2-ylcyclohexyl) acetate Substances 0.000 description 1
- SMOHSULBMKXDEN-RVDMUPIBSA-N (E)-1-N-[2-[[5-[(dimethylamino)methyl]furan-2-yl]methylsulfanyl]ethyl]-2-nitro-1-N'-prop-2-ynylethene-1,1-diamine Chemical compound CN(C)CC1=CC=C(CSCCN\C(NCC#C)=C\[N+]([O-])=O)O1 SMOHSULBMKXDEN-RVDMUPIBSA-N 0.000 description 1
- DTOUUUZOYKYHEP-UHFFFAOYSA-N 1,3-bis(2-ethylhexyl)-5-methyl-1,3-diazinan-5-amine Chemical compound CCCCC(CC)CN1CN(CC(CC)CCCC)CC(C)(N)C1 DTOUUUZOYKYHEP-UHFFFAOYSA-N 0.000 description 1
- KEDVUOWPLAHMLZ-UHFFFAOYSA-N 1-cyano-3-[2-[(5-methyl-1H-imidazol-4-yl)methylsulfanyl]ethyl]-2-prop-2-ynylguanidine Chemical compound CC=1NC=NC=1CSCCNC(NC#N)=NCC#C KEDVUOWPLAHMLZ-UHFFFAOYSA-N 0.000 description 1
- QYXHFICHKVRPSH-UHFFFAOYSA-N 1-cyano-3-[4-[2-(diaminomethylideneamino)-1,3-thiazol-4-yl]butyl]-2-methylguanidine Chemical compound N#CN=C(NC)NCCCCC1=CSC(NC(N)=N)=N1 QYXHFICHKVRPSH-UHFFFAOYSA-N 0.000 description 1
- YFVBASFBIJFBAI-UHFFFAOYSA-M 1-tetradecylpyridin-1-ium;chloride Chemical compound [Cl-].CCCCCCCCCCCCCC[N+]1=CC=CC=C1 YFVBASFBIJFBAI-UHFFFAOYSA-M 0.000 description 1
- IWLUMUDDKHJJPB-UHFFFAOYSA-N 2-(furan-2-ylmethylsulfinyl)-N-[3-[3-(piperidin-1-ylmethyl)phenoxy]propyl]acetamide Chemical compound C=1C=CC(CN2CCCCC2)=CC=1OCCCNC(=O)CS(=O)CC1=CC=CO1 IWLUMUDDKHJJPB-UHFFFAOYSA-N 0.000 description 1
- GOXQRTZXKQZDDN-UHFFFAOYSA-N 2-Ethylhexyl acrylate Chemical compound CCCCC(CC)COC(=O)C=C GOXQRTZXKQZDDN-UHFFFAOYSA-N 0.000 description 1
- CZTPLYMKHNEVHO-UHFFFAOYSA-N 2-[2-[[5-(2-aminopropan-2-yl)furan-2-yl]methylsulfanyl]ethylamino]-5-[(6-methylpyridin-3-yl)methyl]-1H-pyrimidin-6-one Chemical compound C1=NC(C)=CC=C1CC(C(N1)=O)=CN=C1NCCSCC1=CC=C(C(C)(C)N)O1 CZTPLYMKHNEVHO-UHFFFAOYSA-N 0.000 description 1
- MURUHMTVTKOWBY-UHFFFAOYSA-N 2-[2-[[5-[(dimethylamino)methyl]furan-2-yl]methylsulfanyl]ethylamino]-5-[(2-oxo-1H-pyridin-4-yl)methyl]-1H-pyrimidin-6-one Chemical compound O1C(CN(C)C)=CC=C1CSCCNC(NC1=O)=NC=C1CC1=CC(=O)NC=C1 MURUHMTVTKOWBY-UHFFFAOYSA-N 0.000 description 1
- GIMNAEMRNXUAQP-UHFFFAOYSA-N 2-[4-(2-methyl-1H-imidazol-5-yl)-1,3-thiazol-2-yl]guanidine Chemical compound N1C(C)=NC=C1C1=CSC(N=C(N)N)=N1 GIMNAEMRNXUAQP-UHFFFAOYSA-N 0.000 description 1
- RWMSXNCJNSILON-UHFFFAOYSA-N 2-[4-(2-propylpentyl)piperidin-1-yl]ethanol Chemical compound CCCC(CCC)CC1CCN(CCO)CC1 RWMSXNCJNSILON-UHFFFAOYSA-N 0.000 description 1
- VUKAUDKDFVSVFT-UHFFFAOYSA-N 2-[6-[4,5-bis(2-hydroxypropoxy)-2-(2-hydroxypropoxymethyl)-6-methoxyoxan-3-yl]oxy-4,5-dimethoxy-2-(methoxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)-5-methoxyoxane-3,4-diol Chemical compound COC1C(OC)C(OC2C(C(O)C(OC)C(CO)O2)O)C(COC)OC1OC1C(COCC(C)O)OC(OC)C(OCC(C)O)C1OCC(C)O VUKAUDKDFVSVFT-UHFFFAOYSA-N 0.000 description 1
- WDQMWEYDKDCEHT-UHFFFAOYSA-N 2-ethylhexyl 2-methylprop-2-enoate Chemical compound CCCCC(CC)COC(=O)C(C)=C WDQMWEYDKDCEHT-UHFFFAOYSA-N 0.000 description 1
- WOBHKFSMXKNTIM-UHFFFAOYSA-N 2-hydroxyethyl 2-methylacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 1
- OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 description 1
- VHSHLMUCYSAUQU-UHFFFAOYSA-N 2-hydroxypropyl methacrylate Chemical compound CC(O)COC(=O)C(C)=C VHSHLMUCYSAUQU-UHFFFAOYSA-N 0.000 description 1
- JEYKZWRXDALMNG-UHFFFAOYSA-N 2-methyl-5-(methylsulfonylmethyl)-N-[3-[3-(piperidin-1-ylmethyl)phenoxy]propyl]-1,2,4-triazol-3-amine Chemical compound CN1N=C(CS(C)(=O)=O)N=C1NCCCOC1=CC=CC(CN2CCCCC2)=C1 JEYKZWRXDALMNG-UHFFFAOYSA-N 0.000 description 1
- ZAWQXWZJKKICSZ-UHFFFAOYSA-N 3,3-dimethyl-2-methylidenebutanamide Chemical compound CC(C)(C)C(=C)C(N)=O ZAWQXWZJKKICSZ-UHFFFAOYSA-N 0.000 description 1
- YVFNSFYHKSSVRN-UHFFFAOYSA-N 3-N-[3-[3-(piperidin-1-ylmethyl)phenoxy]propyl]-1,2,5-thiadiazole-3,4-diamine;hydrochloride Chemical compound Cl.NC1=NSN=C1NCCCOC1=CC=CC(CN2CCCCC2)=C1 YVFNSFYHKSSVRN-UHFFFAOYSA-N 0.000 description 1
- KSBYXRUNSLGUNE-UHFFFAOYSA-N 3-amino-4-[3-[3-(piperidin-1-ylmethyl)phenoxy]propylamino]cyclobut-3-ene-1,2-dione Chemical compound O=C1C(=O)C(N)=C1NCCCOC1=CC=CC(CN2CCCCC2)=C1 KSBYXRUNSLGUNE-UHFFFAOYSA-N 0.000 description 1
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-Aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 1
- ANAAMBRRWOGKGU-UHFFFAOYSA-M 4-ethyl-1-tetradecylpyridin-1-ium;chloride Chemical compound [Cl-].CCCCCCCCCCCCCC[N+]1=CC=C(CC)C=C1 ANAAMBRRWOGKGU-UHFFFAOYSA-M 0.000 description 1
- PONBXPNEKAYGLH-UHFFFAOYSA-N 4-ethyl-2-methylideneoctanamide Chemical compound CCCCC(CC)CC(=C)C(N)=O PONBXPNEKAYGLH-UHFFFAOYSA-N 0.000 description 1
- CWSZBVAUYPTXTG-UHFFFAOYSA-N 5-[6-[[3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxymethyl]-3,4-dihydroxy-5-[4-hydroxy-3-(2-hydroxyethoxy)-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)-2-methyloxane-3,4-diol Chemical compound O1C(CO)C(OC)C(O)C(O)C1OCC1C(OC2C(C(O)C(OC)C(CO)O2)OCCO)C(O)C(O)C(OC2C(OC(C)C(O)C2O)CO)O1 CWSZBVAUYPTXTG-UHFFFAOYSA-N 0.000 description 1
- WXFIFTYQCGZRGR-UHFFFAOYSA-N 5-hydroxy-2-methylhex-2-enamide Chemical compound CC(O)CC=C(C)C(N)=O WXFIFTYQCGZRGR-UHFFFAOYSA-N 0.000 description 1
- XDDGPSPSTJHUPR-UHFFFAOYSA-N 9,10-dihydrophenanthren-1-ol Chemical compound C1CC2=CC=CC=C2C2=C1C(O)=CC=C2 XDDGPSPSTJHUPR-UHFFFAOYSA-N 0.000 description 1
- 240000006523 Abies balsamea Species 0.000 description 1
- 229940022659 Acetaminophen Drugs 0.000 description 1
- LFVVNPBBFUSSHL-UHFFFAOYSA-N Alexidine Chemical compound CCCCC(CC)CNC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NCC(CC)CCCC LFVVNPBBFUSSHL-UHFFFAOYSA-N 0.000 description 1
- PZZYQPZGQPZBDN-UHFFFAOYSA-N Aluminium silicate Chemical compound O=[Al]O[Si](=O)O[Al]=O PZZYQPZGQPZBDN-UHFFFAOYSA-N 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 235000007119 Ananas comosus Nutrition 0.000 description 1
- 240000002254 Ananas comosus Species 0.000 description 1
- 229940064005 Antibiotic throat preparations Drugs 0.000 description 1
- 229940083879 Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE Drugs 0.000 description 1
- 229940042052 Antibiotics for systemic use Drugs 0.000 description 1
- 229940042786 Antitubercular Antibiotics Drugs 0.000 description 1
- 241001522301 Apogonichthyoides nigripinnis Species 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 240000005781 Arachis hypogaea Species 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N Aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 229960003438 Aspartame Drugs 0.000 description 1
- 239000004852 Asphaltite Substances 0.000 description 1
- 229940098164 Augmentin Drugs 0.000 description 1
- 229940083828 Bioflavonoid drugs for capillary stabilizing Drugs 0.000 description 1
- 229940093797 Bioflavonoids Drugs 0.000 description 1
- 229950002342 Bisfentidine Drugs 0.000 description 1
- 229910000906 Bronze Inorganic materials 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N C[N+](C)(C)CCO Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960003563 Calcium Carbonate Drugs 0.000 description 1
- 229940043256 Calcium Pyrophosphate Drugs 0.000 description 1
- 239000004343 Calcium peroxide Substances 0.000 description 1
- LHJQIRIGXXHNLA-UHFFFAOYSA-N Calcium peroxide Chemical compound [Ca+2].[O-][O-] LHJQIRIGXXHNLA-UHFFFAOYSA-N 0.000 description 1
- JUNWLZAGQLJVLR-UHFFFAOYSA-J Calcium pyrophosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])([O-])=O JUNWLZAGQLJVLR-UHFFFAOYSA-J 0.000 description 1
- DSSYKIVIOFKYAU-UHFFFAOYSA-N Camphor Chemical compound C1CC2(C)C(=O)CC1C2(C)C DSSYKIVIOFKYAU-UHFFFAOYSA-N 0.000 description 1
- 229960000846 Camphor Drugs 0.000 description 1
- 208000008787 Cardiovascular Disease Diseases 0.000 description 1
- 229940085262 Cetyl dimethicone Drugs 0.000 description 1
- 229960004830 Cetylpyridinium Drugs 0.000 description 1
- 229960001231 Choline Drugs 0.000 description 1
- 229960001380 Cimetidine Drugs 0.000 description 1
- CCGSUNCLSOWKJO-UHFFFAOYSA-N Cimetidine Chemical compound N#CNC(=N/C)\NCCSCC1=NC=N[C]1C CCGSUNCLSOWKJO-UHFFFAOYSA-N 0.000 description 1
- 240000004499 Cinnamomum aromaticum Species 0.000 description 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 240000002268 Citrus limon Species 0.000 description 1
- 235000019499 Citrus oil Nutrition 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- KDLRVYVGXIQJDK-AWPVFWJPSA-N Clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N Coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 240000007154 Coffea arabica Species 0.000 description 1
- 235000016795 Cola Nutrition 0.000 description 1
- 240000001644 Cola acuminata Species 0.000 description 1
- 235000011824 Cola pachycarpa Nutrition 0.000 description 1
- 229940108925 Copper Gluconate Drugs 0.000 description 1
- OCUCCJIRFHNWBP-IYEMJOQQSA-L Copper gluconate Chemical compound [Cu+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O OCUCCJIRFHNWBP-IYEMJOQQSA-L 0.000 description 1
- GWFAVIIMQDUCRA-UHFFFAOYSA-L Copper(II) fluoride Chemical compound [F-].[F-].[Cu+2] GWFAVIIMQDUCRA-UHFFFAOYSA-L 0.000 description 1
- JJLJMEJHUUYSSY-UHFFFAOYSA-L Copper(II) hydroxide Chemical compound [OH-].[OH-].[Cu+2] JJLJMEJHUUYSSY-UHFFFAOYSA-L 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L Copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- JYGXADMDTFJGBT-VWUMJDOOSA-N Cortisol Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 1
- HCAJEUSONLESMK-UHFFFAOYSA-N Cyclamic acid Chemical class OS(=O)(=O)NC1CCCCC1 HCAJEUSONLESMK-UHFFFAOYSA-N 0.000 description 1
- GZCGUPFRVQAUEE-KCDKBNATSA-N D-(+)-Galactose Natural products OC[C@@H](O)[C@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-KCDKBNATSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KAZBKCHUSA-N D-Mannitol Natural products OC[C@@H](O)[C@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KAZBKCHUSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- LKDRXBCSQODPBY-VRPWFDPXSA-N D-levulose Chemical compound OCC1(O)OC[C@@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-VRPWFDPXSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N D-sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229950010956 DONETIDINE Drugs 0.000 description 1
- 208000006558 Dental Calculus Diseases 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 206010012601 Diabetes mellitus Diseases 0.000 description 1
- 108010016626 Dipeptides Proteins 0.000 description 1
- MBMBGCFOFBJSGT-KUBAVDMBSA-N Docosahexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 1
- 229960003722 Doxycycline Drugs 0.000 description 1
- XQTWDDCIUJNLTR-CVHRZJFOSA-N Doxycycline Chemical compound O.O=C1C2=C(O)C=CC=C2[C@H](C)[C@@H]2C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]1[C@H]2O XQTWDDCIUJNLTR-CVHRZJFOSA-N 0.000 description 1
- ZQHFZHPUZXNPMF-UHFFFAOYSA-N Ebrotidine Chemical compound S1C(N=C(N)N)=NC(CSCCN=CNS(=O)(=O)C=2C=CC(Br)=CC=2)=C1 ZQHFZHPUZXNPMF-UHFFFAOYSA-N 0.000 description 1
- 229950002377 Ebrotidine Drugs 0.000 description 1
- 229960005135 Eicosapentaenoic Acid Drugs 0.000 description 1
- JAZBEHYOTPTENJ-JLNKQSITSA-N Eicosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 1
- 229940088598 Enzyme Drugs 0.000 description 1
- 229950007285 Etintidine Drugs 0.000 description 1
- 229960005293 Etodolac Drugs 0.000 description 1
- XFBVBWWRPKNWHW-UHFFFAOYSA-N Etodolac Chemical compound C1COC(CC)(CC(O)=O)C2=N[C]3C(CC)=CC=CC3=C21 XFBVBWWRPKNWHW-UHFFFAOYSA-N 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 229960002217 Eugenol Drugs 0.000 description 1
- 210000000416 Exudates and Transudates Anatomy 0.000 description 1
- 229960001596 Famotidine Drugs 0.000 description 1
- XUFQPHANEAPEMJ-UHFFFAOYSA-N Famotidine Chemical compound NC(N)=NC1=NC(CSCCC(N)=NS(N)(=O)=O)=CS1 XUFQPHANEAPEMJ-UHFFFAOYSA-N 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- RDJGLLICXDHJDY-UHFFFAOYSA-N Fenoprofen Chemical compound OC(=O)C(C)C1=CC=CC(OC=2C=CC=CC=2)=C1 RDJGLLICXDHJDY-UHFFFAOYSA-N 0.000 description 1
- 229960001419 Fenoprofen Drugs 0.000 description 1
- FEBLZLNTKCEFIT-VSXGLTOVSA-N Fluocinolone acetonide Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]2(C)C[C@@H]1O FEBLZLNTKCEFIT-VSXGLTOVSA-N 0.000 description 1
- SYTBZMRGLBWNTM-UHFFFAOYSA-N Flurbiprofen Chemical compound FC1=CC(C(C(O)=O)C)=CC=C1C1=CC=CC=C1 SYTBZMRGLBWNTM-UHFFFAOYSA-N 0.000 description 1
- 229960000304 Folic Acid Drugs 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- BJHIKXHVCXFQLS-UYFOZJQFSA-N Fructose Natural products OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)CO BJHIKXHVCXFQLS-UYFOZJQFSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 229960003082 Galactose Drugs 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- 229940087603 Grape Seed Extract Drugs 0.000 description 1
- 229940093922 Gynecological Antibiotics Drugs 0.000 description 1
- 229940093912 Gynecological Sulfonamides Drugs 0.000 description 1
- 206010018987 Haemorrhage Diseases 0.000 description 1
- UQEAIHBTYFGYIE-UHFFFAOYSA-N Hexamethyldisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)C UQEAIHBTYFGYIE-UHFFFAOYSA-N 0.000 description 1
- AQLJVWUFPCUVLO-UHFFFAOYSA-N Hydrogen peroxide - urea Chemical compound OO.NC(N)=O AQLJVWUFPCUVLO-UHFFFAOYSA-N 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- MURRAGMMNAYLNA-UHFFFAOYSA-N Impromidine Chemical compound N1C=NC(CSCCNC(N)=NCCCC=2NC=NC=2)=C1C MURRAGMMNAYLNA-UHFFFAOYSA-N 0.000 description 1
- 229950005073 Impromidine Drugs 0.000 description 1
- 229960000367 Inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N Inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- SERLAGPUMNYUCK-DCUALPFSSA-N Isomalt Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N Kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- DKYWVDODHFEZIM-UHFFFAOYSA-N Ketoprofen Chemical compound OC(=O)C(C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 DKYWVDODHFEZIM-UHFFFAOYSA-N 0.000 description 1
- OZWKMVRBQXNZKK-UHFFFAOYSA-N Ketorolac Chemical compound OC(=O)C1CCN2C1=CC=C2C(=O)C1=CC=CC=C1 OZWKMVRBQXNZKK-UHFFFAOYSA-N 0.000 description 1
- 235000019766 L-Lysine Nutrition 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- 108010029541 Laccase Proteins 0.000 description 1
- 229960003303 Lafutidine Drugs 0.000 description 1
- KMZQAVXSMUKBPD-DJWKRKHSSA-N Lafutidine Chemical compound C=1C=COC=1C[S+]([O-])CC(=O)NC\C=C/COC(N=CC=1)=CC=1CN1CCCCC1 KMZQAVXSMUKBPD-DJWKRKHSSA-N 0.000 description 1
- 229950003849 Lamtidine Drugs 0.000 description 1
- NRIGRKAXOLMTSK-UHFFFAOYSA-N Lamtidine Chemical compound CN1N=C(N)N=C1NCCCOC1=CC=CC(CN2CCCCC2)=C1 NRIGRKAXOLMTSK-UHFFFAOYSA-N 0.000 description 1
- 241000533950 Leucojum Species 0.000 description 1
- 229940040504 Lipotropic Agents Drugs 0.000 description 1
- VTLNPNNUIJHJQB-UHFFFAOYSA-N Loxtidine Chemical compound CN1N=C(CO)N=C1NCCCOC1=CC=CC(CN2CCCCC2)=C1 VTLNPNNUIJHJQB-UHFFFAOYSA-N 0.000 description 1
- 229950000367 Lupitidine Drugs 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 241000218378 Magnolia Species 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N Maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 235000011430 Malus pumila Nutrition 0.000 description 1
- 240000007119 Malus pumila Species 0.000 description 1
- 235000015103 Malus silvestris Nutrition 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 229940041290 Mannose Drugs 0.000 description 1
- 229940013798 Meclofenamate Drugs 0.000 description 1
- SBDNJUWAMKYJOX-UHFFFAOYSA-N Meclofenamic Acid Chemical compound CC1=CC=C(Cl)C(NC=2C(=CC=CC=2)C(O)=O)=C1Cl SBDNJUWAMKYJOX-UHFFFAOYSA-N 0.000 description 1
- HYYBABOKPJLUIN-UHFFFAOYSA-N Mefenamic acid Chemical compound CC1=CC=CC(NC=2C(=CC=CC=2)C(O)=O)=C1C HYYBABOKPJLUIN-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229960004452 Methionine Drugs 0.000 description 1
- 229960000282 Metronidazole Drugs 0.000 description 1
- 229950008866 Mifentidine Drugs 0.000 description 1
- 102000014171 Milk Proteins Human genes 0.000 description 1
- 108010011756 Milk Proteins Proteins 0.000 description 1
- 229960004023 Minocycline Drugs 0.000 description 1
- DYKFCLLONBREIL-KVUCHLLUSA-N Minocycline Chemical compound C([C@H]1C2)C3=C(N(C)C)C=CC(O)=C3C(=O)C1=C(O)[C@@]1(O)[C@@H]2[C@H](N(C)C)C(O)=C(C(N)=O)C1=O DYKFCLLONBREIL-KVUCHLLUSA-N 0.000 description 1
- 240000005561 Musa balbisiana Species 0.000 description 1
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 1
- RWAXQWRDVUOOGG-UHFFFAOYSA-N N,2,3-trimethyl-2-propan-2-ylbutanamide Chemical compound CNC(=O)C(C)(C(C)C)C(C)C RWAXQWRDVUOOGG-UHFFFAOYSA-N 0.000 description 1
- VLNBKZOBXNLNGX-UHFFFAOYSA-N N-(2-ethylhexyl)-2-methylprop-2-enamide Chemical compound CCCCC(CC)CNC(=O)C(C)=C VLNBKZOBXNLNGX-UHFFFAOYSA-N 0.000 description 1
- BSCJIBOZTKGXQP-UHFFFAOYSA-N N-(2-hydroxyethyl)-2-methylprop-2-enamide Chemical compound CC(=C)C(=O)NCCO BSCJIBOZTKGXQP-UHFFFAOYSA-N 0.000 description 1
- UUORTJUPDJJXST-UHFFFAOYSA-N N-(2-hydroxyethyl)prop-2-enamide Chemical compound OCCNC(=O)C=C UUORTJUPDJJXST-UHFFFAOYSA-N 0.000 description 1
- IPGRTXQKFZCLJS-UHFFFAOYSA-N N-(2-hydroxypropyl)prop-2-enamide Chemical compound CC(O)CNC(=O)C=C IPGRTXQKFZCLJS-UHFFFAOYSA-N 0.000 description 1
- HIVRCMFJEMKPDS-UHFFFAOYSA-N N-[2-[[5-[(dimethylamino)methyl]furan-2-yl]methylsulfanyl]ethyl]-1-oxidopyridin-1-ium-3-carboxamide Chemical compound O1C(CN(C)C)=CC=C1CSCCNC(=O)C1=CC=C[N+]([O-])=C1 HIVRCMFJEMKPDS-UHFFFAOYSA-N 0.000 description 1
- GOZUADYOHPCXLE-UHFFFAOYSA-N N-[4-(1H-imidazol-5-yl)phenyl]-N'-propan-2-ylmethanimidamide Chemical compound C1=CC(NC=NC(C)C)=CC=C1C1=CN=CN1 GOZUADYOHPCXLE-UHFFFAOYSA-N 0.000 description 1
- FXJAOWANXXJWGJ-UHFFFAOYSA-N N-[4-(2-methyl-1H-imidazol-5-yl)phenyl]-N'-propan-2-ylmethanimidamide Chemical compound C1=CC(NC=NC(C)C)=CC=C1C1=CN=C(C)N1 FXJAOWANXXJWGJ-UHFFFAOYSA-N 0.000 description 1
- VQGWOOIHSXNRPW-UHFFFAOYSA-N N-butyl-2-methylprop-2-enamide Chemical compound CCCCNC(=O)C(C)=C VQGWOOIHSXNRPW-UHFFFAOYSA-N 0.000 description 1
- YRVUCYWJQFRCOB-UHFFFAOYSA-N N-butylprop-2-enamide Chemical compound CCCCNC(=O)C=C YRVUCYWJQFRCOB-UHFFFAOYSA-N 0.000 description 1
- QQZXAODFGRZKJT-UHFFFAOYSA-N N-tert-butyl-2-methylprop-2-enamide Chemical compound CC(=C)C(=O)NC(C)(C)C QQZXAODFGRZKJT-UHFFFAOYSA-N 0.000 description 1
- CMWTZPSULFXXJA-VIFPVBQESA-N Naproxen Chemical compound C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 description 1
- 239000004384 Neotame Substances 0.000 description 1
- HLIAVLHNDJUHFG-HOTGVXAUSA-N Neotame Chemical compound CC(C)(C)CCN[C@@H](CC(O)=O)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 HLIAVLHNDJUHFG-HOTGVXAUSA-N 0.000 description 1
- 229940053207 Niacin Drugs 0.000 description 1
- SGXXNSQHWDMGGP-IZZDOVSWSA-N Nizatidine Chemical compound [O-][N+](=O)\C=C(/NC)NCCSCC1=CSC(CN(C)C)=N1 SGXXNSQHWDMGGP-IZZDOVSWSA-N 0.000 description 1
- 229960004872 Nizatidine Drugs 0.000 description 1
- 229950002404 Octapinol Drugs 0.000 description 1
- 235000006297 Origanum majorana Nutrition 0.000 description 1
- 240000000783 Origanum majorana Species 0.000 description 1
- 241000237502 Ostreidae Species 0.000 description 1
- 235000011829 Ow cola Nutrition 0.000 description 1
- 108020005203 Oxidases Proteins 0.000 description 1
- 229940055729 Papain Drugs 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- 229940072417 Peroxidase Drugs 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 108090000437 Peroxidases Proteins 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 240000005158 Phaseolus vulgaris Species 0.000 description 1
- 229960002895 Phenylbutazone Drugs 0.000 description 1
- XNGIFLGASWRNHJ-UHFFFAOYSA-N Phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 1
- QYSPLQLAKJAUJT-UHFFFAOYSA-N Piroxicam Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC1=CC=CC=N1 QYSPLQLAKJAUJT-UHFFFAOYSA-N 0.000 description 1
- 229920001100 Polydextrose Polymers 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K Potassium citrate Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 1
- OKBMCNHOEMXPTM-UHFFFAOYSA-M Potassium peroxymonosulfate Chemical compound [K+].OOS([O-])(=O)=O OKBMCNHOEMXPTM-UHFFFAOYSA-M 0.000 description 1
- OTYBMLCTZGSZBG-UHFFFAOYSA-L Potassium sulfate Chemical compound [K+].[K+].[O-]S([O-])(=O)=O OTYBMLCTZGSZBG-UHFFFAOYSA-L 0.000 description 1
- AVTYONGGKAJVTE-UHFFFAOYSA-L Potassium tartrate Chemical compound [K+].[K+].[O-]C(=O)C(O)C(O)C([O-])=O AVTYONGGKAJVTE-UHFFFAOYSA-L 0.000 description 1
- 229940111695 Potassium tartrate Drugs 0.000 description 1
- 208000005107 Premature Birth Diseases 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 240000002799 Prunus avium Species 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J Pyrophosphate Chemical class [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- FZUOVNMHEAPVBW-UHFFFAOYSA-L Quinoline Yellow WS Chemical compound [Na+].[Na+].O=C1C2=CC=CC=C2C(=O)C1C1=NC2=C(S([O-])(=O)=O)C=C(S(=O)(=O)[O-])C=C2C=C1 FZUOVNMHEAPVBW-UHFFFAOYSA-L 0.000 description 1
- 229950010771 Ramixotidine Drugs 0.000 description 1
- VMXUWOKSQNHOCA-LCYFTJDESA-N Ranitidine Chemical compound [O-][N+](=O)/C=C(/NC)NCCSCC1=CC=C(CN(C)C)O1 VMXUWOKSQNHOCA-LCYFTJDESA-N 0.000 description 1
- 229960000620 Ranitidine Drugs 0.000 description 1
- 206010057190 Respiratory tract infection Diseases 0.000 description 1
- 229960002477 Riboflavin Drugs 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- AUNGANRZJHBGPY-OUCADQQQSA-N Riboflavin Natural products OC[C@@H](O)[C@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-OUCADQQQSA-N 0.000 description 1
- 229960003320 Roxatidine Drugs 0.000 description 1
- XPQXBTYQDZUYSF-UHFFFAOYSA-L S(=O)(=O)([O-])[O-].[Zn+2].[Na+] Chemical compound S(=O)(=O)([O-])[O-].[Zn+2].[Na+] XPQXBTYQDZUYSF-UHFFFAOYSA-L 0.000 description 1
- 235000002912 Salvia officinalis Nutrition 0.000 description 1
- UKLNMMHNWFDKNT-UHFFFAOYSA-M Sodium chlorite Chemical compound [Na+].[O-]Cl=O UKLNMMHNWFDKNT-UHFFFAOYSA-M 0.000 description 1
- GCLGEJMYGQKIIW-UHFFFAOYSA-H Sodium hexametaphosphate Chemical compound [Na]OP1(=O)OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])O1 GCLGEJMYGQKIIW-UHFFFAOYSA-H 0.000 description 1
- MWNQXXOSWHCCOZ-UHFFFAOYSA-M Sodium percarbonate Chemical compound [Na+].OOC([O-])=O MWNQXXOSWHCCOZ-UHFFFAOYSA-M 0.000 description 1
- ABBQHOQBGMUPJH-UHFFFAOYSA-M Sodium salicylate Chemical compound [Na+].OC1=CC=CC=C1C([O-])=O ABBQHOQBGMUPJH-UHFFFAOYSA-M 0.000 description 1
- UGTZMIPZNRIWHX-UHFFFAOYSA-K Sodium trimetaphosphate Chemical compound [Na+].[Na+].[Na+].[O-]P1(=O)OP([O-])(=O)OP([O-])(=O)O1 UGTZMIPZNRIWHX-UHFFFAOYSA-K 0.000 description 1
- 239000004376 Sucralose Substances 0.000 description 1
- CZMRCDWAGMRECN-GDQSFJPYSA-N Sucrose Natural products O([C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1)[C@@]1(CO)[C@H](O)[C@@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-GDQSFJPYSA-N 0.000 description 1
- 229950002504 Sufotidine Drugs 0.000 description 1
- MLKXDPUZXIRXEP-MFOYZWKCSA-N Sulindac Chemical compound CC1=C(CC(O)=O)C2=CC(F)=CC=C2\C1=C/C1=CC=C(S(C)=O)C=C1 MLKXDPUZXIRXEP-MFOYZWKCSA-N 0.000 description 1
- 229960000894 Sulindac Drugs 0.000 description 1
- 229960002180 Tetracycline Drugs 0.000 description 1
- OFVLGDICTFRJMM-WESIUVDSSA-N Tetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O OFVLGDICTFRJMM-WESIUVDSSA-N 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- 240000000280 Theobroma cacao Species 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- MGSRCZKZVOBKFT-UHFFFAOYSA-N Thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- 235000015450 Tilia cordata Nutrition 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- 240000006909 Tilia x europaea Species 0.000 description 1
- UPSPUYADGBWSHF-UHFFFAOYSA-N Tolmetin Chemical compound C1=CC(C)=CC=C1C(=O)C1=CC=C(CC(O)=O)N1C UPSPUYADGBWSHF-UHFFFAOYSA-N 0.000 description 1
- 229940024982 Topical Antifungal Antibiotics Drugs 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- UEVAMYPIMMOEFW-UHFFFAOYSA-N Trolamine salicylate Chemical compound OCCN(CCO)CCO.OC(=O)C1=CC=CC=C1O UEVAMYPIMMOEFW-UHFFFAOYSA-N 0.000 description 1
- 229960004799 Tryptophan Drugs 0.000 description 1
- 229940045997 Vitamin A Drugs 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Vitamin C Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- 229940046009 Vitamin E Drugs 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N Xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 Xylitol Drugs 0.000 description 1
- 229960003487 Xylose Drugs 0.000 description 1
- 229950003675 Zaltidine Drugs 0.000 description 1
- 229940091251 Zinc Supplements Drugs 0.000 description 1
- WOHVONCNVLIHKY-UHFFFAOYSA-L [Ba+2].[O-]Cl=O.[O-]Cl=O Chemical compound [Ba+2].[O-]Cl=O.[O-]Cl=O WOHVONCNVLIHKY-UHFFFAOYSA-L 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O Chemical class [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K [O-]P([O-])([O-])=O Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000003082 abrasive agent Substances 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 229950010221 alexidine Drugs 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 125000005250 alkyl acrylate group Chemical group 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 235000012741 allura red AC Nutrition 0.000 description 1
- 239000004191 allura red AC Substances 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 229920002892 amber Polymers 0.000 description 1
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 description 1
- 229960003022 amoxicillin Drugs 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000010617 anise oil Substances 0.000 description 1
- 230000003042 antagnostic Effects 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000000844 anti-bacterial Effects 0.000 description 1
- 229940121363 anti-inflammatory agents Drugs 0.000 description 1
- 239000008122 artificial sweetener Substances 0.000 description 1
- 235000021311 artificial sweeteners Nutrition 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- 239000010620 bay oil Substances 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229940095076 benzaldehyde Drugs 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid group Chemical group C(C1=CC=CC=C1)(=O)O WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000003115 biocidal Effects 0.000 description 1
- 229910052626 biotite Inorganic materials 0.000 description 1
- 150000004287 bisbiguanides Chemical class 0.000 description 1
- 230000000740 bleeding Effects 0.000 description 1
- 231100000319 bleeding Toxicity 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- 239000010974 bronze Substances 0.000 description 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-M buffer Substances [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 1
- SOGAXMICEFXMKE-UHFFFAOYSA-N butyl 2-methylprop-2-enoate Chemical compound CCCCOC(=O)C(C)=C SOGAXMICEFXMKE-UHFFFAOYSA-N 0.000 description 1
- 235000019282 butylated hydroxyanisole Nutrition 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 235000019402 calcium peroxide Nutrition 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- QXIKMJLSPJFYOI-UHFFFAOYSA-L calcium;dichlorite Chemical compound [Ca+2].[O-]Cl=O.[O-]Cl=O QXIKMJLSPJFYOI-UHFFFAOYSA-L 0.000 description 1
- 229930007890 camphor Natural products 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 239000007765 cera alba Substances 0.000 description 1
- NEUSVAOJNUQRTM-UHFFFAOYSA-N cetylpyridinium Chemical compound CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 NEUSVAOJNUQRTM-UHFFFAOYSA-N 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 235000019693 cherries Nutrition 0.000 description 1
- 230000035606 childbirth Effects 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 229930002875 chlorophylls Natural products 0.000 description 1
- 229940117916 cinnamic aldehyde Drugs 0.000 description 1
- 239000010630 cinnamon oil Substances 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 229930007907 citral Natural products 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 239000010500 citrus oil Substances 0.000 description 1
- 229960002227 clindamycin Drugs 0.000 description 1
- 239000010634 clove oil Substances 0.000 description 1
- FDJOLVPMNUYSCM-UVKKECPRSA-L cobalt(3+);[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2R)-1-[3-[(2R,3R,4Z,7S,9Z,12S,13S,14Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7, Chemical compound [Co+3].N#[C-].C1([C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)[N-]\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O FDJOLVPMNUYSCM-UVKKECPRSA-L 0.000 description 1
- 229960004126 codeine Drugs 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- 229940110767 coenzyme Q10 Drugs 0.000 description 1
- 235000016213 coffee Nutrition 0.000 description 1
- 235000013353 coffee beverage Nutrition 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 150000001879 copper Chemical class 0.000 description 1
- CFQJFBMLIAGCOU-UHFFFAOYSA-N copper;chromium(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Cr+3].[Cr+3].[Cu+2] CFQJFBMLIAGCOU-UHFFFAOYSA-N 0.000 description 1
- DXKGMXNZSJMWAF-UHFFFAOYSA-N copper;oxido(oxo)iron Chemical compound [Cu+2].[O-][Fe]=O.[O-][Fe]=O DXKGMXNZSJMWAF-UHFFFAOYSA-N 0.000 description 1
- 239000000973 cosmetic coloring agent Substances 0.000 description 1
- JPVYNHNXODAKFH-UHFFFAOYSA-N cu2+ Chemical class [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 239000004053 dental implant Substances 0.000 description 1
- 201000002170 dentin sensitivity Diseases 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 235000019821 dicalcium diphosphate Nutrition 0.000 description 1
- 229960001259 diclofenac Drugs 0.000 description 1
- DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 235000016693 dipotassium tartrate Nutrition 0.000 description 1
- 229960004363 doconexent Drugs 0.000 description 1
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 1
- 229940090949 docosahexaenoic acid Drugs 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 229930003935 flavonoids Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 229960002390 flurbiprofen Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 238000005755 formation reaction Methods 0.000 description 1
- 239000004867 fossil resin Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N fumaric acid Chemical compound OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- 229930008393 geraniol Natural products 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 235000009754 grape Nutrition 0.000 description 1
- 235000012333 grape Nutrition 0.000 description 1
- 235000002532 grape seed extract Nutrition 0.000 description 1
- 229920000591 gum Polymers 0.000 description 1
- 235000017423 hawthorn Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229960004867 hexetidine Drugs 0.000 description 1
- 235000019534 high fructose corn syrup Nutrition 0.000 description 1
- 239000003485 histamine H2 receptor antagonist Substances 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 229960001680 ibuprofen Drugs 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 230000002452 interceptive Effects 0.000 description 1
- 229940079866 intestinal antibiotics Drugs 0.000 description 1
- 229940079867 intestinal antiinfectives Sulfonamides Drugs 0.000 description 1
- 229960004903 invert sugar Drugs 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000000905 isomalt Substances 0.000 description 1
- 235000010439 isomalt Nutrition 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229960000991 ketoprofen Drugs 0.000 description 1
- 229960004752 ketorolac Drugs 0.000 description 1
- 239000011021 lapis lazuli Substances 0.000 description 1
- RYZCLUQMCYZBJQ-UHFFFAOYSA-H lead(2+);dicarbonate;dihydroxide Chemical compound [OH-].[OH-].[Pb+2].[Pb+2].[Pb+2].[O-]C([O-])=O.[O-]C([O-])=O RYZCLUQMCYZBJQ-UHFFFAOYSA-H 0.000 description 1
- 229960001518 levocarnitine Drugs 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- 229960004232 linoleic acid Drugs 0.000 description 1
- 239000003912 lipotropic agent Substances 0.000 description 1
- KAGBQTDQNWOCND-UHFFFAOYSA-M lithium;chlorite Chemical compound [Li+].[O-]Cl=O KAGBQTDQNWOCND-UHFFFAOYSA-M 0.000 description 1
- 231100000533 low birth weight Toxicity 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 229960003646 lysine Drugs 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- NWAPVVCSZCCZCU-UHFFFAOYSA-L magnesium;dichlorite Chemical compound [Mg+2].[O-]Cl=O.[O-]Cl=O NWAPVVCSZCCZCU-UHFFFAOYSA-L 0.000 description 1
- YRZGPQDNADQQOW-UHFFFAOYSA-L magnesium;potassium;phthalate Chemical compound [Mg+2].[K+].[O-]C(=O)C1=CC=CC=C1C([O-])=O YRZGPQDNADQQOW-UHFFFAOYSA-L 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229960001855 mannitol Drugs 0.000 description 1
- 229960003803 meclofenamic acid Drugs 0.000 description 1
- 229960003464 mefenamic acid Drugs 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 239000001683 mentha spicata herb oil Substances 0.000 description 1
- LPEKGGXMPWTOCB-UHFFFAOYSA-N methyl 2-hydroxypropionate Chemical compound COC(=O)C(C)O LPEKGGXMPWTOCB-UHFFFAOYSA-N 0.000 description 1
- 229940057867 methyl lactate Drugs 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 description 1
- 235000021239 milk protein Nutrition 0.000 description 1
- 230000003278 mimic Effects 0.000 description 1
- 229910052627 muscovite Inorganic materials 0.000 description 1
- 229960002009 naproxen Drugs 0.000 description 1
- 235000021096 natural sweeteners Nutrition 0.000 description 1
- 229960004927 neomycin Drugs 0.000 description 1
- 235000019412 neotame Nutrition 0.000 description 1
- 108010070257 neotame Proteins 0.000 description 1
- WTEVQBCEXWBHNA-YFHOEESVSA-N neral Chemical compound CC(C)=CCC\C(C)=C/C=O WTEVQBCEXWBHNA-YFHOEESVSA-N 0.000 description 1
- 230000000926 neurological Effects 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 1
- 230000000050 nutritive Effects 0.000 description 1
- 235000014571 nuts Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 1
- 229940005935 ophthalmologic Antibiotics Drugs 0.000 description 1
- 229940005938 ophthalmologic antiinfectives Sulfonamides Drugs 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 235000020636 oyster Nutrition 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N p-acetaminophenol Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- 229960005489 paracetamol Drugs 0.000 description 1
- 239000010663 parsley oil Substances 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- PNIJRIIGBGFYHF-UHFFFAOYSA-N perborate(2-) Chemical compound O[B-]1(O)OO[B-](O)(O)OO1 PNIJRIIGBGFYHF-UHFFFAOYSA-N 0.000 description 1
- 230000003239 periodontal Effects 0.000 description 1
- JRKICGRDRMAZLK-UHFFFAOYSA-L peroxydisulfate Chemical compound [O-]S(=O)(=O)OOS([O-])(=O)=O JRKICGRDRMAZLK-UHFFFAOYSA-L 0.000 description 1
- VYMDGNCVAMGZFE-UHFFFAOYSA-N phenylbutazonum Chemical compound O=C1C(CCCC)C(=O)N(C=2C=CC=CC=2)N1C1=CC=CC=C1 VYMDGNCVAMGZFE-UHFFFAOYSA-N 0.000 description 1
- 229910052628 phlogopite Inorganic materials 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 229960002702 piroxicam Drugs 0.000 description 1
- 229920001485 poly(butyl acrylate) polymer Polymers 0.000 description 1
- 229920001490 poly(butyl methacrylate) polymer Polymers 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920001483 poly(ethyl methacrylate) polymer Polymers 0.000 description 1
- 229920002454 poly(glycidyl methacrylate) polymer Polymers 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920002721 polycyanoacrylate Polymers 0.000 description 1
- 229920002776 polycyclohexyl methacrylate Polymers 0.000 description 1
- 239000001259 polydextrose Substances 0.000 description 1
- 235000013856 polydextrose Nutrition 0.000 description 1
- 229940035035 polydextrose Drugs 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 229960002816 potassium chloride Drugs 0.000 description 1
- 239000001508 potassium citrate Substances 0.000 description 1
- 229960002635 potassium citrate Drugs 0.000 description 1
- 235000010333 potassium nitrate Nutrition 0.000 description 1
- 239000004323 potassium nitrate Substances 0.000 description 1
- 229940093928 potassium nitrate Drugs 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 229910052939 potassium sulfate Inorganic materials 0.000 description 1
- 229940093914 potassium sulfate Drugs 0.000 description 1
- 235000011151 potassium sulphates Nutrition 0.000 description 1
- 239000001472 potassium tartrate Substances 0.000 description 1
- VISKNDGJUCDNMS-UHFFFAOYSA-M potassium;chlorite Chemical compound [K+].[O-]Cl=O VISKNDGJUCDNMS-UHFFFAOYSA-M 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 125000004368 propenyl group Chemical group C(=CC)* 0.000 description 1
- 229960002862 pyridoxine Drugs 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- KAESVJOAVNADME-UHFFFAOYSA-N pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 1
- 235000012752 quinoline yellow Nutrition 0.000 description 1
- 230000001603 reducing Effects 0.000 description 1
- 230000001105 regulatory Effects 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 229960003287 roxatidine acetate Drugs 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 239000001296 salvia officinalis l. Substances 0.000 description 1
- 238000007790 scraping Methods 0.000 description 1
- 230000001953 sensory Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 229910052604 silicate mineral Inorganic materials 0.000 description 1
- 229960002218 sodium chlorite Drugs 0.000 description 1
- 235000019982 sodium hexametaphosphate Nutrition 0.000 description 1
- 235000010344 sodium nitrate Nutrition 0.000 description 1
- 239000004317 sodium nitrate Substances 0.000 description 1
- 229940045872 sodium percarbonate Drugs 0.000 description 1
- 229960004025 sodium salicylate Drugs 0.000 description 1
- MWNQXXOSWHCCOZ-UHFFFAOYSA-L sodium;oxido carbonate Chemical compound [Na+].[O-]OC([O-])=O MWNQXXOSWHCCOZ-UHFFFAOYSA-L 0.000 description 1
- YKOLYTVUIVUUDY-UHFFFAOYSA-K sodium;zinc;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Na+].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O YKOLYTVUIVUUDY-UHFFFAOYSA-K 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000019721 spearmint oil Nutrition 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000003637 steroidlike Effects 0.000 description 1
- 159000000008 strontium salts Chemical class 0.000 description 1
- 235000019408 sucralose Nutrition 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- SJMYWORNLPSJQO-UHFFFAOYSA-N tert-butyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OC(C)(C)C SJMYWORNLPSJQO-UHFFFAOYSA-N 0.000 description 1
- ISXSCDLOGDJUNJ-UHFFFAOYSA-N tert-butyl prop-2-enoate Chemical compound CC(C)(C)OC(=O)C=C ISXSCDLOGDJUNJ-UHFFFAOYSA-N 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 1
- 235000019529 tetraterpenoid Nutrition 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 229960002898 threonine Drugs 0.000 description 1
- 229930007823 thymol Natural products 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 229960001017 tolmetin Drugs 0.000 description 1
- 230000036347 tooth sensitivity Effects 0.000 description 1
- 229940026752 topical Sulfonamides Drugs 0.000 description 1
- 230000002588 toxic Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- 239000011791 tripotassium citrate Substances 0.000 description 1
- 235000015870 tripotassium citrate Nutrition 0.000 description 1
- 235000012141 vanillin Nutrition 0.000 description 1
- 229940117960 vanillin Drugs 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 150000003712 vitamin E derivatives Chemical class 0.000 description 1
- 239000001717 vitis vinifera seed extract Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N α-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- GLZPCOQZEFWAFX-JXMROGBWSA-N β-Geraniol Chemical compound CC(C)=CCC\C(C)=C\CO GLZPCOQZEFWAFX-JXMROGBWSA-N 0.000 description 1
- OZJPLYNZGCXSJM-UHFFFAOYSA-N δ-Valerolactone Chemical compound O=C1CCCCO1 OZJPLYNZGCXSJM-UHFFFAOYSA-N 0.000 description 1
Abstract
A tooth coating comprising at least 10%by weight of a natural resin system comprising at least two natural resins;a colorant;and pearlescent particles. Methods of coloring a tooth and methods of preventing or treating oral care conditions are also provided.
Description
COMPOSITIONS FOR COATING TEETH AND METHODS
RELATED REQUEST
This application claims the priority of the patent application of the United States of America series number 10 / 775,706 filed on February 10, 2004, the contents of which are incorporated herein by reference.
INTRODUCTION
This invention relates to compositions and methods for whitening or coloring the teeth. The invention also relates to compositions and methods for applying orally or pharmaceutically active care agents, such as anti-caries agents or breath fresheners for teeth.
Consumers who want to whiten or color their teeth have a limited variety of products to choose from. The successful application of some products such as varnishes, crowns and lids, involves the destruction of the enamel of the teeth, and requires the service of a dental professional such as a dentist. In addition, teeth whitening or coloring products have not been used as carriers for active materials such as pharmaceutically active compounds, anti-cavity agents or breath fresheners.
Therefore, there is a continued need for new compositions and methods for whitening teeth, in particular compositions and methods for whitening teeth without the destruction of tooth enamel, as well as compositions and methods for delivering active materials to the oral cavity.
SYNTHESIS
The present invention provides compositions and methods for imparting whiteness or color to teeth, using natural or synthetic resins and at least one colorant. In several embodiments, the present invention provides a coating for teeth comprising at least 10% by weight of a natural resin system comprising at least two natural resins, a dye, and talking particles. In several embodiments, the coating of the teeth comprises a natural resin system comprising at least two different resins, a dye, talking particles, and an active material. In one embodiment, the present invention provides a tooth coating composition comprising at least 10% of a natural resin system comprising rosin, mastic and shellac;
the titanium dioxide dye and the titanium mica pearl particle.
The present invention also provides methods for coloring a tooth in a human or other animal subject which comprises applying to a tooth a coating comprising: at least 10% by weight of a natural resin system comprising at least two natural resins, a dye, and pearled particles. The present invention also provides a method for preventing or treating a condition for oral care in a human or other animal subject which comprises applying to a tooth of said subject a coating composition comprising at least 10% by weight of a system of natural resin comprising at least two natural resins, a dye and a pearled particle and an active for oral care.
It has been discovered that the compositions and methods of this invention provide advantages over temporary bleaching compositions among those known in the art including one or more of aesthetics and improved coloring efficacy, improved stability in the oral cavity including, improved adhesion of the coating of teeth to the surface of the tooth in the presence of saliva, and the delivery of benefits for oral care. Additional uses, benefits, and modifications of the present invention are apparent from the description set forth herein.
DETAILED DESCRIPTION
The following description of the preferred incorporation or incorporations is merely exemplary in nature and it is not intended to limit the invention in any way, nor in its application or uses.
The following non-limiting definitions and guidelines should be considered in the review of the description of this invention as set forth herein. The headings (such as "introduction" and "summary") used herein are intended only for a general organization of the topics within the description of the invention and are not intended to limit the description of the invention or any aspect thereof. In particular, the subject matter described in the "introduction" may include aspects of technology within the scope of the invention and may not constitute a recitation of prior art. The subject matter described in the "synthesis" is not an exhaustive or complete description of the full scope of the invention or any incorporations thereof. The classification or discussion of a material within this section of this description as having a particular utility (for example as being a "system") is done for convenience and no inference should be drawn that the material must necessarily or only function in accordance with its classification given here when it is used in any given composition.
The citation references given herein do not constitute an admission that those references are prior art or that they have any relevance to the patentability of the invention described herein. All references cited in the description section of this specification are incorporated herein by reference in their entirety.
The description and specific examples, even when indicating embodiments of the invention, are intended for purposes of illustration only and are not intended to limit the scope of the invention. In addition, the recitation of multiple incorporations having the declared characteristics is not intended to exclude other incorporations that have additional characteristics or other incorporations that incorporate different combinations of the declared characteristics. The specific examples are provided for illustrative purposes of how to make and use the compositions and methods of this invention and, unless explicitly stated otherwise, they are not intended to be a representation that given the embodiments of the invention are made or not done or tested.
As used herein, the words "preferred" and "preferably" refer to embodiments of the invention that provide certain benefits, under certain circumstances. However, other additions may also be preferred, under the same or other circumstances. In addition, the recitation of one or more preferred embodiments does not imply that other embodiments are not useful, and is not intended to exclude other embodiments from the scope of the invention.
As used here, the word "includes", and its variants, is intended to be non-limiting, so that this recitation of items in a list is not for the exclusion of other similar items that may also be useful in the materials, compositions, devices and methods of this invention.
As mentioned herein, all percentages of composition are by weight of the total composition unless otherwise specified.
The articles "a" and "an" as used herein indicate "at least one" of the article that is present. As used herein, the term "around" when applied to the value for a parameter of a composition or method of this invention indicates that the calculation or measurement of the value allows some slight inaccuracy without having a substantial effect on the chemical or physical attributes of the composition or method. If, for some reason, the inaccuracy provided by "around" is not otherwise understood in the art with this, ordinary meaning, then "around" is used here to indicate a possible variation of up to 5% in value.
Teeth Coating Compositions
According to several embodiments of the present invention, a tooth coating composition is provided to impart a color, preferably a natural white color, to a tooth surface. The surface of the tooth is generally composed of tooth enamel, and the bleaching composition makes contact and preferably adheres to the tooth enamel to impart an immediate discernible coloring effect, thereby rapidly altering the color of the tooth surface. As mentioned herein "tooth" or "teeth" refers to natural teeth, dentures, dental plates, fillings, caps, crowns, bridges, dental implants and the like, and any hard surface dental prosthesis either permanently or temporarily fixed within of the oral cavity.
As used herein, "blanched" refers to a change in visual appearance of a tooth, preferably so that the tooth has a brighter hue. The color change of a tooth surface can be observed visually, for example with the help of meters or color comparison charts or can be measured by colorimetry, using any suitable instrument such as a Minolta Chromameter, for example the CR-400 model (from Minolta Corporation, of Ramsey, New Jersey). The instrument can be programmed, for example, to measure the Hunter Lab values or the L * a * b * values according to the standard established by the International Lighting Committee (CIÉ). The system L * a * b * provides a numerical representation of three-dimensional color space where L * represents a brightness axis, a * represents a red-green axis and b * represents a yellow-blue axis. The axes L * and b * are typically of greater application to the measurement of whiteness of the tooth. The increase in whiteness can be computed from the differences in the values L *, a * and b * before and after the treatment, or between the untreated and treated surfaces. A useful parameter is? E *, calculated as the square root of the sum of the squares of the differences in the values L *, a * and b * using the formula:
? E * = [(? L *) 2 + (? A *) 2 + (? B *) 2] 1/2
A higher value of? E * indicates a greater increase in whiteness. In various embodiments, the method of the present invention can perform an "E *" of at least about 1, or at least about 3, or at least about, or at least about .
The present invention includes tooth coating compositions and methods for imparting whiteness or color to the teeth. Such compositions comprise at least 10% of a natural resin system, a colorant, and pearlescent particles. The dye and pearlescent particles can impart whiteness or a non-white color to the teeth. The application of the compositions to the teeth in a mammal such as, for example, a human, covers the teeth and imparts whiteness or a color to the teeth.
Natural Resin System
The natural resin system of the embodiments of the present invention comprises at least two different natural resins different from one another. As used herein, "natural resins" includes plant resins (e.g., those derived from plant sources) and animal resins (e.g., those derived from animal sources). Such resins include plant resins such as from trees, shrubs and seed exudates of recent origin, fossil resins, mined resins such as asphaltite, and resins derived from animals, such as derived from shellac from lacquer insects. The selection of the natural resins used in the system can be based on factors such as: 1) desired hardness of the coating of the teeth, 2) desired level and longevity of adhesion of the tooth coating to the teeth, 3) attributes of film formation , 4) the type of dye and pearlescent particles used, and 5) inclusion of additional active ingredients.
Natural resins vary based on the number of acid, polarity, molecular weight, softening point or a geographical origin of the resin. The standard classifications of natural resins by the American Rubber Importers Association include dammars, oriental indians, copal, acroids, elemi, mastic, sandarac and colophonium, all of which are suitable for incorporations of the present invention. Natural resins can take the form of rosins, distillates, saps, oils, balsams or gums, subcomponents thereof and mixtures thereof.
The natural resins useful in the tooth coating compositions of the present invention are in or can be obtained from natural sources in their unmodified state. The natural resin can also be modified. The modification of the natural resin may include processing steps, such as purification, for example, to remove colored contaminants, such as chromophoric impurities and other compounds which may be undesirable for inclusion in certain embodiments of the coating composition. of the tooth. Other example modifications include the isolation of constituents to separate a subcomponent from other constituents or to increase the concentration of desired subcomponents. Such purification may result in a tooth coating that is whiter than a comparable tooth coating in which the impurities have not been removed from the natural resin.
Modified resins also include chemical derivatives, for example, maleic modified oils, phenolic modified rosin ester resins, maleic modified rosin ester resin, hydrogenated rosin, and the like. Additional chemical alterations of the natural resin include, but are not limited to, the polymerization of a resin, copolymerization of a resin, copolymerization of various resins, and the creation of a synthetic resin that essentially mimics the attributes (acid number, polarity, weight molecular, softening point, etc.) of a natural resin from a living source.
The tooth coating preferably comprises a natural film-forming resin system. The concentration of the total film-forming resin system can be from at least about 10% to about 95%, from around 15% to around 90%, from around 20% to around 85%, from around 25% or 26% to around 60%, 70%, or 80%, or from around 30% to around 60%. In the preferred embodiments, the natural resin system comprises a mixture of at least one resin derived from the plant and at least one resin derived from animal or insect. Such a natural resin system comprises a mixture of colophonium and mastic (two plants derived from natural resins) and shellac (a natural resin derived from an insect). A useful shellac here is commercially available as Bulls Eye® shellac marketed by Zinsser Company, Inc. (of Somerset, New Jersey, E.U.A.).
A tooth coating of several incorporations optionally further comprises a synthetic polymer blended with a natural resin system. The term "polymer" as used herein, may encompass both acid and salt forms of homopolymers, copolymers, block copolymers, graft copolymers, crosslinked polymers, polymerizable monomers and salts thereof, and monomers that polymerize in conjunction with the application to a tooth. Non-limiting examples of the polymers within the scope of the present invention may include polyacrylamide, polymethacrylate, polyethylene glycol, polyvinyl pyrrolidone, hydroxypropyl methyl cellulose, hydroxypropyl cellulose, hydroxyethyl cellulose, methyl cellulose, carboxymethyl cellulose, crosslinked polyvinyl pyrrolidone, polyvinyl pyrrolidone copolymer vinyl acetate, polyvinyl alcohol, polyacrylate, polyacrylic acid, crosslinked polyacrylate, crosslinked polyacrylic acid, polyethylene oxide, polyethylene glycol, polyvinyl alkyl, maleic acid ether copolymer, carboxyvinyl polymer, polystyrene and combinations thereof. In some configurations, a polyvinyl pyrrolidone may be a polyvinyl pyrrolidone provided by International Specialty Products, of Wayne, New Jersey. In some configurations, a hydroxypropyl cellulose may be the Klucel® hydroxypropyl cellulose supplied by Hercules, Inc. of Wilmington, Delaware, E.U.A. In some configurations, the synthetic polymer may comprise at least about 90%, at least about 95%, at least about 96%, at least about 97%, at least about 98%, per at least about 99% or a greater percent of a monomeric repeat unit.
In configurations where the polymer comprises polymerizable monomers and salts thereof, a polymer may comprise at least about 90%, at least about 95%, at least about 96%, at least about 97 %, at least about 98%, at least about 99% or a greater percent of a monomer.
As noted above, in certain embodiments, the synthetic polymer can be a polyacrylate. Non-limiting examples of the polyacrylates of the present invention include of the present invention include polyacrylate, crosslinked polyacrylates, alkyl acrylates such as polymethacrylate, alicyclic, aromatic, heterocyclic and polyacrylate containing vinyl group, hydroxy containing polyacrylates, such as alkoxy polyacrylates, polyacrylates containing carboxylic acid, polycyanoacrylates, polidialquilaminoetilacrilatos, polyethyl polifluoroalquilacrilatos, polybutylacrylate such as poly n-butalacrilato and poly t-butyl acrylate, poly 2- ethylhexylacrylate, policiclohexilacrilato, polibencilacrilato, poly 2-hydroxyethyl acrylate, hydroxypropyl acrylate-poli2, polidimetilaminoetilacrilato, polidietilaminoetilacrilato, poliglicidilacrilato, politetrahidrofurfuril acrylate; poly alkyl methacrylates, such as polymethyl methacrylate, polyethyl methacrylate, poly di and tri methacrylates, polymethacrylates containing vinyl and alicyclic group, -aromatic, heterocyclic, hydroxy-containing polymethacrylates such as poly alkoxymethacrylates, poly dialkylaminoethyl methacrylates, polyfluoroalkyl methacrylates, polybutyl methacrylate such as poly n- butyl methacrylate, poly t-butyl methacrylate, poly 2-ethylhexyl methacrylate, poly cyclohexyl methacrylate, polybenzylmethacrylate, poly 2-hydroxyethyl methacrylate, poly 2-hydroxypropylmethacrylate, polydimethylaminoethyl methacrylate, polydiethylaminoethyl methacrylate, polyglycidyl methacrylate, and polytetrahydrofufurfuryl methacrylate. In the embodiment, the compositions of the present invention comprise rosin, mastic and a polyacrylate.
In some embodiments, the synthetic polymer can be a polyacrylamide or a substituted polyacrylamide. Non-limiting examples of polyacrylamides include polyacrylamide, crosslinked polyacrylamides, alkyl archilamides such as polymethacrylamide, polyacrylamides containing vinyl and heterocyclic group, aromatic and alicyclic, polyacrylamides containing hydroxy such as alkoxy polyacrylamides, polyacrylamides containing carboxylic acid, polydialkylaminoethyl acrylamides, polyfluoroalkyl acrylamides, polyethylacrylamide, polybutylacrylamide, as poly n-butylacrylamide and poly t-butylacrylamide, poly 2-ethylhexylacrylamide, polycyclohexylacrylamide, polybenzylacrylamide, poly 2-hydroxyethyl acrylamide, poly 2-hydroxypropyl acrylamide, polydimethylaminoethyl acrylamide, polydiethylaminoethyl acrylamide, polyglycidyl acrylamide, polytetrahydrofurfuryl acrylamide, alkyl methacrylamides, such as polymethyl methacrylamide, polyethyl methacrylamide, polymethacrylamides containing vinyl group and heterocyclics, alicyclic aromatics, polymethacrylamides containing hydroxy such as alkoxymethacrylamides, poly di and tri methacrylamide ions, polydialkylaminoethyl methacrylamides, polyfluoroalkyl methacrylamides, polybutylmethacrylamide such as poly n-butyl methacrylamide and t-butyl methylacrylamide, poly 2-ethylhexyl methacrylamide, polycyclohexyl methacrylamide, polybenzyl acrylamide, polybenzyl methacrylamide, poly 2-hydroxyethyl methacrylamide, poly 2-hydroxypropyl methacrylamide, polydimethylaminoethyl methacrylamide, polydiethylaminoethyl methacrylamide, polyglycidyl methacrylamide, and polytetrahydrofurfuryl methacrylamide.
In embodiments where the polymer is a monomer that polymerizes in conjunction with the application to a tooth, a tooth coating composition may comprise a cyanoacrylate monomer. The polymerization of the cyanoacrylate monomers can be initiated with contact with an aqueous fluid such as, for example, saliva on the surface of a tooth. Similarly, a tooth coating composition can comprise a toxic monomer which can be polymerized upon contacting the composition with an initiator soon after or before application to a tooth.
In several embodiments, the natural film-forming resin system (and the optional synthetic polymer) used in the compositions given herein may have a weight average molecular weight, an average number-average molecular weight, a Z-average molecular weight or a weight viscosity average molecular from about 100 to about 5,000,000; from around 200 to around 2,500,000; from about 500 to about 1,000,000; from about 1,000 to about 5,000,000; or from around 10,000 to around 125,000.
In several embodiments, a tooth coating is a tooth coating fluid. "Fluid" as used herein means a non-solid and non-gaseous substance. In several embodiments, the fluid may be liquid or a semi-solid. The viscosity of a fluid can vary from freely flowing, low viscosity to extremely high viscosity in which the flow is slow or almost imperceptible to a human without help under environmental conditions. For example, ordinary silica glass, such as glass comprised of a window pane, can be considered a fluid here. A fluid here can be, in certain embodiments, a thixotropic liquid. A "semi-solid" as used herein may be a gel, a colloid, a paste, an ointment or a gum. As used herein, semi-solids and liquids are distinguished fluids based on viscosity: a semi-solid is a high viscosity fluid, while a liquid has a lower viscosity. There is no definitive division line between these types of fluids. A fluid of a tooth coating composition given herein can have a viscosity, measured at 25 ° C, ranging from about 0.18 millipascal-seconds (mPa-s) to about 100,000,000 millipascal-seconds, from about 0.5. milipascal-seconds to about 10,000,000 millipascal-seconds, from about 1 millipascal-second to about 1,000,000 millipascal-seconds, from about 1.5 millipascal-seconds to around 100,000 millipascal-seconds, or from from around 2 milipascal-seconds to around 10, 000 pascal-seconds. In some configurations, a fluid of a composition herein can have a viscosity of from about 100 to about 1,000 Pa-s. Without being limited by theory, it is believed that the viscosity of a given fluid here will vary with the amount (percentage) of a natural film-forming resin system and the weight average molecular weight of natural film-forming resins.
In several embodiments, a tooth coating as described herein may be an adhesive fluid that adheres to the teeth. Without being limited by theory, it is believed that the adhesives of the fluid of the present invention will vary with the amount (percent) of the natural film-forming resin system, and the weight average molecular weight of a natural film-forming resin. Adhesiveness can be measured using standard adhesion tests known in the art, for example, the adhesive test described in United States of America patent number 6,613,812 issued to Bui et al., Issued September 2, 2003. certain embodiments, the adhesiveness between a tooth and a film formed of a fluid of the present invention can be from about 3.4 megapascals (MPa), at least 6.9 megapascals, at least 13.8 megapascals, or more.
In various embodiments of the present invention, a tooth-coating composition comprises a natural film-forming resin system that can form a film on a surface of the teeth after application thereto. In some embodiments, a formulation of a composition may comprise the natural resin system and the volatile solvent which may dissolve the resin. The solvent may be, for example, an organic solvent, such as an alcohol, for example, ethanol. In several embodiments, the compositions of the present invention comprise a solvent in an amount of from about 1% to about 70%, from about 10% to about 50%, from about 20% to about 40%. %, from around 25% to around 35%. In some embodiments, a film may be formed when the solvent is removed, for example, through evaporation. In some embodiments, a film can be formed as monomers composed of the polymerized composition. Without being limited by theory, it is believed that the longevity of a film, for example the period of time during which the film remains intact on the teeth, will vary with the percentage amount of the natural film-forming resin system in the film. and the weight average molecular weight of natural resins.
In various embodiments, a skilled artisan may select a percentage amount and a weight average molecular weight of a polymer composed of a composition herein depending on the intended use. For example, a user who wishes to color their teeth for one night may use a formulation comprising a low percentage of resin and / or a resin of low average molecular weight, while a user desiring a tooth coating that lasts several months it can use a formulation comprising a high percentage of resin and / or a resin of high average molecular weight.
Colorant
The coatings of the teeth of the incorporations of the present invention may comprise at least one colorant. The term "colorant" as used to describe here a substance that can impart a color when applied to a tooth. A color, as used here, can be any hue, dye or remnant perceptible, including but not limited to the spectrum colors, to the colors comprised within the color space L * a * b *, the colors comprised within the space RGB color, as well as black, brown, gray and white. A color imparted to a tooth by a tooth coating fluid described herein may be a white color or a non-white color. In various embodiments, the colorant may be a pigment or a dye. In certain embodiments, a pigment can be a white pigment that can impart a white color to a tooth.
In some configurations, the colorant may comprise a plurality of pigment particles. A pigment, as used herein, can mean a particulate colorant. In some configurations, the compositions of the present invention may comprise one or more dyes at a concentration, individually, or in total, from about 0.1% (w / w) to about 20%, from about 1% to about 19%, from about 2% to about 18%, from about 3% to about 17%, from about 4% to about 16%, or from about 6% to about of 15%. In some configurations, the pigment particles can have an average size of from about 0.1 micrometers to about 1000 micrometers, from about 0.3 micrometers to about 100 micrometers, or from about 0.5 micrometers to about 50 micrometers in size. diameter or the longest dimension.
In several embodiments, the colorant is a white pigment. The white pigment can be, for example, a white polymer. In some configurations, the white polymer can be a polymer as described in U.S. Patent No. 6,669,930 issued to Hoic. Non-limiting examples of such polymers include polyethylene, polypropylene, ethylene / propylene copolymer, polytetrafluohylene and polyhexafluoropropene. Specific examples of the white polymers include polyethylene PE220, polypropylene and polytetrafluohylene (PTFE), as supplied by Pre-Sperse, Inc. (of Somerset, New Jersey, E.U.A.). Such white polymers may be high molecular weight polymers having a weight average molecular weight, an average number molecular weight, an average Z-molecular weight, an average viscosity molecular weight of from about 100 to about 10,000,000.; from around 200 to around 5,000,000; from about 500 to about 1,000,000; from about 1,000 to about 500,000; from around 10,000 to around 100,000 or from around 20,000 to around 50,000.
In some configurations, the white pigment may comprise metal oxide such as, for example, titanium oxide, aluminum oxide, tin oxide, calcium oxide, magnesium oxide, zinc oxide or a combination thereof.
In several embodiments, the colorant is a non-white colorant. In some configurations, the non-white colorant comprises an organic pigment. In certain embodiments, the non-white colorant may be a dye tested for incorporation into a food, drug or cosmetic by a regulatory agency, such as for example FD &C or D &C pigments and dyes approved by the food administration and drugs to be used in the United States of America. Non-limiting examples of non-white dyes include FD &C red # 3 (tetraiodofluorescein sodium salt), Food red 17, 6-hydroxy-5-. { (2-methoxy-5-methyl-4-sulfophenyl) azo} -2-naphthalene sulphonic acid, food yellow 13, quinophthalone monosulfonic acid, quinophthalone disulfonic acid, 2- (2-quinolyl) indedione monosulfonic acid, 2- (2-quinolyl) indanedione disulfonic acid, FD &C yellow No 5, FD &C yellow No. 6, FD &C green No. 3, FD &C blue No. 1, FD &C blue No. 2, D &C red # 30, phthalocyanine green, salts thereof and mixtures thereof.
In some embodiments, the non-white colorant is a dye lacquer pigment. In some configurations, the dye lacquer may be an aluminum or calcium salt of an FD &C dye such as, for example, FD &C green # 1 shellac, FD &C blue # 2 shellac, D &C red # 30 lacquer or FD &C yellow # 15 lacquer, or mixtures thereof.
In several embodiments, the non-white colorant comprises an inorganic pigment. Non-limiting examples of the inorganic pigments may include certain metal oxide pigments such as, for example, copper oxide, iron oxide and chromium oxide. Other non-white inorganic pigments which may be comprised by a coating of teeth alone or in combination may be, for example, mineral pigments such as ultramarine blue (lapis lazuli).
In certain configurations, the colorant comprises a dye contained within a water insoluble polymer. In a non-limiting example, the blue FD &C # 1 dye may be contained within a water-insoluble polymer such as polyethylene such as that found in polyethylene beads (e.g., Microblue Spectrabeads, from Micropowders, Inc. Tarrytown, New York, USA). In certain embodiments, the colorant may be a non-bleeding dye.
Pearl particles
The coatings of the teeth of the embodiments of the present invention may comprise pearlescent particles. In some configurations, the pearlescent particles may provide a white pearl color. In other configurations, the pearlescent particles may provide a non-white pearly color. "Pearl" and "pearl" as used herein may refer to an optical property of a material in which the material has a lustrous pearl-like appearance. A pearlized material can provide a sense of depth and brightness and can be aesthetically appealing. Without being limited by theory, pearlescent particles are believed to partially reflect and partially refract incidental light. The extent of reflection or refraction of incident light by a pearlized material may depend on the angle of incidence of light and / or the angle of vision. As used herein, "pearly" may include iridescence and opalescence. Pearl materials may appear monochromatic or appear to change color depending on the viewing angle.
The pearlescent particles used in the compositions given herein can provide aesthetic or cosmetic effects such as, for example, luster or spark. In some configurations, a composition may comprise monochromatic pearlized particles. In some configurations, a composition may comprise pearlescent particles having a variety of colors. A tooth coating composition may comprise pearlescent particles of from about 0.1% to about 20%, from about 1% to about 19%, from about 2% to about 18%, from about 3% to around 17%, from around 4% to around 16%, or from around 6% to around 15%. In some configurations, the pearled particles can have an average size of from about 0.5 micrometers to about 500 micrometers, from about 1 micrometer to about 100 micrometers, or from about 2 micrometers to about 20 micrometers in diameter or of the longest dimension.
The pearlescent particles may comprise a single material or a unique chemical species, such as, for example, a silicate such as mica, or bismuth oxychloride.
By "mica" is meant any one of the group of hydrous aluminum silicate minerals with a flat morphology and a basal excision (micaceous). The mica can be, for example, sheet mica, residue mica, or leaflet mica as exemplified by the micas of the muscovite, biotite or phlogopite type. In the embodiments, the pearlescent particles may comprise a complex comprising more than one mineral or chemical species, such as, for example, mica coated with metal oxide such as titanium oxide. In some embodiments, the pearled particles may comprise at least one non-white component such as iron oxide, may comprise an optical interference composition, for example as provided by certain iridescent or opalescent minerals, such as opal, or compositions comprising mica coated with one or more layers of titanium oxide. The pearlized particles can also be of biological origin, for example fish scales or mother-of-pearl. Certain pearly particles of biological origin may comprise calcium carbonate, such as, for example, pearl, mollusk shell such as mother of pearl obtained from the oyster shell or nacre.
In some embodiments, pearlescent particles comprise those described as pigments
Timiron®, Colorona® pigments, Dichrona® pigments, Soloron® pigments, Biron® powders, Biron® dispersions, dispersions
Nailsyn® or Microna® matte colors (all trademarks EM Industries, Inc. of Hawthorne, New York, E.U.A., E. Merck division). For example, the mica titanium particles may be pearlescent particles such as Timiron® particles.
The white or pearlescent mica titanium particles can be, for example, the "Silverwhite" Timiron® particles such as
Timiron® Starluster MP-115, Timiron® Supersheen MP-1001,
Timiron® Sparkle MP-47, Timiron® Supersol, MP-1005, Timiron®
Peral Flake MP-10, Timiron® Pear Sheen MP-30, Timiron® Super
Silver Fine, Timiron® Gleamer Flake MP-111, Timiron® Ultraluster MP-45, Timiron® Transwhite MP-18, Timiron® Diamond
Cluster MP-149, Timiron® Super Silver, Timiron® Stardust MP-80, Timiron® Arctic Silver or Timiron® Snowflake MP-99.
In some configurations, the mica particles may comprise mica and a metal oxide such as titanium oxide in a non-white color, presenting for example, an interference-based or iridescent color. For example, a tooth coating may comprise a gold pigment such as Timiron® Gold Plus MP-25, Timiron® Sun Gold Sparkle MP-29, Timiron® Fine Gold MP-20, Timiron® Transgold MP-28 or Timiron® Karat. Gold MP-24; an interfering pigment, such as Timiron® Super Green, Timiron® Super Blue, Timiron® Super Red, Timiron® Gold MP-127, Timiron® Blue MP-155, Timiron® Super Gold, Timiron® Gold Glow MP-26, Timiron® Silk gold, Timiron® silk red, Timiron® silk blue, Timiron® silk green,
Timiron® super copper, Timiron® super violet, Timiron® red starlight, Timiron® blue starlight, Timiron® gold starlight,
Timiron® green starlight, Timiron® Splendid gold, splendid red Timiron®, splendid blue Timiron®, splendid green Timiron®, splendid Copper Timiron® or splendid Violet Timiron® or a metallic-colored pigment such as Timiron®
MP-60 Bronze or Timiron® MP-65 Copper. In some configurations, a fluid may comprise multiple types of pigments for cosmetic or aesthetic effects.
Non-Polymer Material
In various configurations, the coating fluid of the teeth of the present invention further comprises one or more additional components, such as in non-limiting examples, a non-polymeric organic hydrophobic material. The organic non-polymeric material can be, for example, a wax, such as a beeswax, for example a white beeswax or a paraffin. In various embodiments, the composition may comprise a non-polymeric hydrophobic material at a level of from about 0.01% to about 2% (w / w).
In the preferred embodiments, a tooth coating of the present invention comprises a natural resin system, an alcohol solvent, and a non-polymeric hydrophobic material. For example, a tooth coating of the present invention may comprise a natural resin system comprising rosin, slab, and shellac; an ethanol and paraffin solvent as the non-polymeric hydrophobic material. The natural resin system may be present in the coating of. tooth at about 70%, ethanol may be present at less than about 30%, and paraffin may be present at less than about 1%. Specifically, the natural resin system may comprise about 33% rosin, about 12% slab and about 22% shellac of the tooth coating.
Sweeteners
In several embodiments, a sweetener is employed in the tooth coatings of the present invention. Sweeteners among those useful herein include orally acceptable nutritive or non-nutritive, natural or artificial sweeteners. Such sweeteners include dextrose, polydextrose, sucrose, maltose, dextrin, dried invert sugar, mannose, xylose, ribose, fructose, levulose, galactose, corn syrup (including high fructose corn syrup and corn syrup solids), partially starch hydrolyzed, hydrolyzed hydrogenated starch, sorbitol, mannitol, xylitol, maltitol, isomalt, aspartame, neotame, saccharin and salts thereof, sucralose, intense sweeteners based on dipeptide, cyclamates, dihydrochalcones and mixtures thereof. One or more sweeteners are optionally present in a total amount depending strongly on the particular sweeteners or selected sweeteners, but typically at levels of from about 0.01% to about 5% by weight, and preferably from about 0.5% to about 2% by weight. Sodium saccharin is preferred for certain additions.
Flavoring Agent
The bleaching compositions of the teeth of the present invention optionally comprise a flavoring agent. Flavors among those useful herein include any material or mixture of operable materials to improve the flavor of the composition. Any orally acceptable natural or synthetic flavor may be used, such as flavor oils, flavoring aldehydes, esters, alcohols, similar materials and combinations thereof. Flavors include vanillin, sage, marjoram, parsley oil, spearmint oil, cinnamon oil, pyrrole oil (methyl salicylate), peppermint oil, clove oil, bay oil, anise oil, eucalyptus oil, citrus oils, oils and fruit essences, including those derived from lemon, orange, lime, grapefruit, peach, banana, grape, apple, strawberry, cherry, pineapple, bean and nut derived flavors such as cocoa, coffee, cola, peanut , almonds, etc., adsorbed and encapsulated flavorings and mixtures thereof. Also encompassed within the flavorings cited herein are ingredients that provide fragrance and / or other sensory effect in the mouth, including cooling or heating effects. Such ingredients include menthol, menthyl acetate, methyl lactate, camphor, eucalyptus oil, eucalyptol, acetol, eugenol, cassia, oxanone, a-irisone, propenyl guaietol, thymol, linalool, benzaldehyde, cinnamaldehyde, N-ethyl-p-methane. 3-carboxamine, N, 2, 3-trimethyl-2-isopropylbutanamide, 3-1-methoxypropane-1, 2-diol, cinnamaldehyde glycerol acetal (CGA), methane glycerol acetal (MGA), and mixtures thereof. One or more flavors are optionally present in a total amount of from about 0.03% to about 5% by weight, optionally in several additions of from about 0.2 to about 1% by weight.
Systemic and Oral Care Assets
In several embodiments, an active material is included in the bleaching compositions of the present invention. In some additions, the optional active ingredient is a "systemic active" which is operable to try to avoid a disorder which, in whole or in part is not of a disorder of the oral cavity. In several embodiments, the active is an operable "oral care asset" to try to avoid a disorder or provide a cosmetic benefit within the oral cavity (e.g., teeth, gums, or other hard or soft tissues of the oral cavity). The oral cavity The assets for oral care among those useful here include bleaching agents, anti-cavity agents, tartar control agents, periodontal actives, abrasives, breath fresheners agents against odor, tooth desensitizers, saliva stimulators, antibacterial agents, and combinations thereof.It is still understood when the general attributes of each of the above categories of assets may differ, there may be Some common attributes and any given material can serve multiple purposes within two or more of such asset categories. of the active materials are described in U.S. Patent No. 6,596,298 issued to Leung et al., and in U.S. Patent Application No. 10 / 739,803, issued to Boyd et al. and filed on October 18. December 2003.
The compositions of the present invention can also be used for the treatment or prevention of systemic disorders, such as the improvement of overall systemic health characterized by the reduction in the risk of the development of systemic diseases, such as cardiovascular disease, shock, diabetes, severe respiratory infection, infants of low birth weight and premature births (including dysfunction after childbirth depending on development / neurological) and an increased risk of mortality. Such methods include those described in U.S. Patent Application No. 2003/0206874, issued to Doyle et al., Published November 6, 2003.
In some configurations, a bleaching agent can be, in a non-limiting example, a peroxide, a hypochlorite, a peroxide acid, a metal chlorite, a perborate, a percarbonate such as sodium percarbonate, a persulfate such as oxone as described in the patent of the United States of America number 6,419,906 granted to Xu et al., and granted on July 16, 2002, or an oxidoreductase. A peroxide compound can be, for example, a hydrogen peroxide, a urea peroxide, or a calcium peroxide. A metal chlorite can be, for example, a calcium chlorite, a barium chlorite, a magnesium chlorite, a lithium chlorite, a sodium chlorite or a potassium chlorite. An oxidoreductase can be, for example, an enzyme described in U.S. Patent No. 5,989,526 issued to Aaslyng et al. On November 23, 1999, such as laccase, an oxidase or a peroxidase.
The compositions of the present invention optionally comprise an antimicrobial agent (eg, antibacterial). One or more such agents may be present. Suitable examples include without limitation the copper (II) compounds such as copper (II) chloride, fluoride, sulfate and hydroxide, sources of zinc ion such as zinc acetate, zinc citrate, zinc gluconate, zinc glycinate. , zinc oxide, zinc sulfate and zinc sodium citrate, salts and phthalic acid thereof such as magnesium monopotassium phthalate, hexetidine, octenidin, sanguinarin, banzalkonium chloride, dominoen bromide, alkyl pyridinium chlorides such as chloride of cetylpyridinium (CPC)
(Including combinations of CPC with zinc and / or enzymes), tetradecylpyridinium chloride and N-tetradecyl-4-ethylpyridinium chloride, iodine, sulfonamides, bisbiguanides such as alexidine, chlorhexidine and digulconato chlorohexidine, piperidino derivatives such as delmofinol and octapinol , magnolia extract, grapeseed extract, menthol, geraniol, citral, eucalyptol, antibiotics such as augmentin such, amoxicillin, tetracycline, doxycycline, minocycline, metronidazole, neomycin, kanamycin and clindamycin, and the like.
Other suitable antibacterial agents include the nonionic and anionic antibacterial agents known to one skilled in the art. Exemplary nonionic antibacterial agents include water insoluble non-cationic antibacterial agents essentially such as alkylphenoxy phenols; the cycloalkyl phenoxyphenols; 9,10- dihydrophenanthrenol; alkylphenols; cycloalkyl phenols; phenolic compounds; halogenated carbanilides; halogenated salicylanilides; benzoic esters; halogenated diphenyl ethers and mixtures thereof. A particularly suitable nonionic antibacterial agent is a diphenyl ether such as 2,4,4'-trichloro-2'-hydroxyphenyl ether (Triclosan) and 2,2'-dihydrixi-5, 5'-dibromodiphenyl ether. An additional illustrative list of useful antibacterial agents is provided in U.S. Patent No. 5,776,435 issued to Gaffar et al., July 7, 1998 and incorporated herein by reference. One or more antimicrobial agents are optionally present in a total antimicrobial effective amount, typically from about 0.05% to about 10%, for example from about 0.1% to about 3% by weight, of the composition.
The compositions of the present invention optionally comprise an antioxidant. Any orally acceptable antioxidant can be used, including butylated hydroxyanisole (BHA), butylated hydroxytoluene
(BHT), vitamin A, carotenoids, vitamin E, flavonoids, polyphenols, ascorbic acid, herbal antioxidants, chlorophyll, maltonin and mixtures thereof.
The compositions of the present invention optionally comprise an orally acceptable zinc ion source useful, for example, as an antimicrobial agent, against the calculation or refreshing of the breath. One or more such sources may be present. Suitable zinc ion sources include without limitation zinc acetate, zinc citrate, zinc gluconate, zinc glycinate, zinc oxide, zinc sulfate, sodium zinc sulfate and the like. One or more sources of zinc ion are optionally and illustratively present in a total amount of from about 0.05% to about 3%, for example from about 0.1% to about 1%, by weight of the composition.
The compositions of the present invention optionally comprise an agent against the plate (eg plate switch). One or more of such agents may be present in a total antiplaque effective amount. Suitable antiplaque agents include without limitation the stannous, copper, magnesium and strontium salts, the dimethicone copolyol, such as copolyol cetyl dimethicone, papina, glucoamylase, glucose oxidase, urea, calcium lactate, calcium glycerophosphate, strontium polyacrylates of agents chelators such as citric and tartaric acids and alkali metal salts thereof.
The compositions of the present invention optionally comprise an anti-inflammatory agent. One or more of such agents may be present in a total effective anti-inflammatory amount. Suitable anti-inflammatory agents include without limitation spheroidal agents such as flucinolone and hydrocortisone, and non-steroidal agents (NSAIDs) such as ketorolac, flurbiprofen, ibuprofen, naproxen, indomethacin, diclofenac, etodolac, indomethacin, sulindac, tolmetin, ketoprofen , fenoprofen, piroxicam, nabucometone, aspirin, diflunisai, meclofenamate, mefenamic acid, oxifenbutazone and phenylbutazone. One or more anti-inflammatory agents are optionally present in the composition in an anti-inflammatory effective amount.
The compositions of the present invention optionally comprise a histamine H2 receptor antagonist. The H2 antagonists useful herein include cimetidine, etintidine, ranitidine, ICIA-5165, thiothidine, ORF-17578, lupitidine, donetidine, famotidine, roxatidine, pifatidine, lamtidine, BL-6548, BMY-25271, zaltidine, nizatidine, mifentidine, BMY- 42368, SKF-94482, BL-5341A, ICI-162846, ramixotidine, Wy-45727, SR-48042, BMY-25405, loxitidine, da-4634, bisfentidine, sufotidine, ebrotidine, HE-30-256, D-16637, FRG-8813, FRG-8701, impromidine, L-643728, HB-408.4 and mixtures thereof.
The compositions of the present invention optionally comprise a tooth sensitivity or desensitizing agent. One or more such agents may be present. Suitable desensitizing agents include without limitation potassium salts such as potassium citrate, potassium tartrate, potassium chloride, potassium sulfate and potassium nitrate. Another suitable desensitizing agent is sodium nitrate. Alternatively or in addition a local systemic analgesic such as aspirin, codeine, acetaminophen, sodium salicylate or triethanolamine salicylate can be used. One or more desensitizing and / or analgesic agents are optionally present in an analgesic and / or desensitizing effective amount, typically from about 0.05% to about 5%, for example from about 0.1% to about 3% by weight, of the composition.
In some configurations, a scale control agent can be, in a non-limiting example, a dialkali metal or tetralcalin pyrophosphate salt such as Na4P207, K4P207, a2K2P2? 7, Na2H2P2? 7 and K2H2P207; and a long chain polyphosphate such as sodium hexametaphosphate; and a cyclic phosphate such as sodium trimetaphosphate. In some configurations, a polyphosphate may be a β-phase calcium pyrophosphate as described in U.S. Patent No. 6,241,974 issued to White Jr., et al., Issued June 5, 2001.
In some configurations, a breath freshening agent can be an odor reducing agent. An odor reducing agent may be a sulfide precipitating agent. Non-limiting examples of the sulfide precipitating agents include metal salts, such as copper salt and zinc salt. Non-limiting examples of such salts include copper gluconate, zinc citrate and zinc gluconate.
The compositions of the present invention optionally comprise a nutrient. Suitable nutrients include vitamins, minerals, amino acids and mixtures thereof. Vitamins include vitamins C and D, thiamin, riboflavin, calcium pantothenate, niacin, folic acid, nicotinamide, pyridoxine, cyanocobalmin, para-aminobenzoic acid, bioflavonoids and mixtures thereof. Nutritional supplements include amino acids (such as L-tryptophan, L-lysine, methionine, threonine, levocarnitine and L-carnitine), lipotropic agents (such as choline, inositol, betaine, and linoleic acid), fish oil (including components of such as polyunsaturated fatty acids omega-3 (N-3) eicosapentaenoic acid and docosahexaenoic acid), coenzyme Q10 and mixtures thereof.
The compositions of the present invention optionally comprise proteins. Suitable proteins include milk proteins and enzymes such as peroxide-producing enzymes, amylase, plaque-disrupting agents, such as papain, glucoamylase and glucose oxidase.
The compositions of the present invention optionally comprise additional ingredients such as plate buffers such as urea, calcium lactate, calcium glycerophosphate and strontium polyacrylates.
METHODS
In several embodiments, the present invention provides methods for coloring a tooth in a mammal. The mammal can be a human or a non-human higher order mammal such as a cat, dog or horse for example. The methods may comprise applying to a tooth a coloring amount of teeth of a fluid comprising one or more cosmetic coloring agents and a natural film-forming resin system or a synthetic polymer. In some compositions of the present invention, the synthetic polymer or natural resin is present at a level of at least about 10%, of at least about 15%, of at least about 20%, of at least about 25%, of at least about 26% or at least about 30%. In some embodiments, the natural resin is present at a level of at least 25%, 26% or at least about 30%. The coating of the tooth can be a fluid as described above. In some configurations, the coloring agents may comprise one or more white and / or pearly coloring agents. In a preferred embodiment, the white or pearlescent coloring agent comprises titanium oxide, titanium mica or a white polymer as described herein.
The application of a fluid composition of the present invention can be accomplished using any suitable method known in the art. For example, an applicator such as a brush may be immersed in a tooth coating fluid described herein, and the fluid may then be painted on a tooth. In addition to brush application, other non-limiting methods of application may comprise applying a rinse comprising a tooth coating fluid, applying a semi-solid tooth coating fluid from a bar that resembles a lipstick, applying a semisolid using a crayon-type bar, a spray on the fluid, smearing on the fluid using a wipe, or transferring the fluid from an adhesive strip. After the application of a fluid of the invention to the specific teeth, a film adherent to the teeth comprises the natural resin system, a dye and a pearled particle can be formed. The addition of a film to a tooth can be promoted by allowing the fluid to dry after application to the tooth so that a film forms on the teeth. A film once formed can remain on the tooth for at least 1 hour to about 1 year, from from about 1 day to about 6 months, from about 1 week to about 3 months, or from about 2 weeks to about 2 months. A film formed on a tooth can be removed, for example, by friction, for example by providing by brushing teeth or mechanical scraping or in some embodiments, through the application of a solvent, such as for example ethanol. Furthermore, in some configurations, the application of a composition of the invention to a tooth can have a beneficial therapeutic effect, even without the presence of a therapeutic active in the composition, since the composition prevents the acids present in the oral cavity from contact with the tooth.
In certain embodiments, the application of a fluid of the present invention to the teeth does not require special equipment or training; for example, the fluid can be self-applied by an individual user or applied by a beautician. In some configurations, prior to application to the target teeth, the teeth can be cleaned, for example by brushing to promote good adhesion of the fluid. Alternatively, a dental professional such as a dental hygienist or a dentist can clean the target teeth more fully using professional equipment and methods prior to fluid application. Immediately after the application, the solvent composed of the applied fluid can be removed, for example, through evaporation or polymerization of monomers to form a polymer can be allowed to occur. In some configurations, a tooth coating composition that is expected to last for an extended period, for example, for six months after application, may be applied by a dental professional such as a dentist or dental hygienist.
Certain embodiments of the present invention may be illustrated by the following non-limiting examples.
EXAMPLE 1
This example illustrates the composition of the invention comprising a natural resin system with white and pearl pigments. In this example, a fluid comprising a mixture of the following substances can be provided in the amounts designated as shown in table 1:
Table 1
EXAMPLE 2
This example illustrates a method for making the composition described in Example 1.
In this example, titanium dioxide in an amount of 14% (w / w) and a mica titanium Timiron® in an amount of 16.7% (w / w) are mixed with the "Duraphat®;
Placebo "(Colgate-Palmolive Company) at 69.3% (w / w). 'Duraphat® Placebo is the oral adherent pharmaceutical sodium fluoride product of Duraphat® teeth prepared without sodium fluoride.The composition of the Duraphat® Placebo provided in table 2.
Table 2
EXAMPLE 3
This example illustrates a formulation for a resin blend alternated to the Duraphat® Placebo.
As shown in Table 3, the Duraphat® Placebo of the formulation present in Table 2 can be replaced with a mixture of the formulation presented in Table 3. This formulation is expected to provide increased whiteness to the final composition (already the user's teeth) compared to the Duraphat® Placebo due to a natural resin (shellac) which can be amber, which is replaced with a synthetic polymer without color (polyacrylate).
Table 3
The examples and other embodiments described herein are an example and are not intended to be limiting in the description of the full scope of the compositions and methods of this invention. Equivalent changes, modifications and variations of the specific incorporations, materials, compositions and methods can be made within the scope of the present invention with essentially similar results.
Claims (25)
1. A coating for tooth comprising: at least 10% by weight of a film formed of a natural resin system comprising at least two natural resins; a colorant; Y pearled particles,
2. A tooth coating as claimed in clause 1, characterized in that the natural resin is selected from the group consisting of plant resins, animal resins, and combinations thereof.
3. A tooth coating as claimed in clause 2, characterized in that said natural resin system comprises at least one plant resin and at least one insect resin.
4. A tooth coating as claimed in clause 1, characterized in that at least one of said natural resins is selected from the group consisting of dam ars, East Indies, copal, acroids, elemi, almacigo, sandarac, colophonium, shellac and mixtures thereof.
5. A tooth coating as claimed in clause 1, characterized in that said natural resin is provided in a form selected from the group consisting of: natural unmodified resins, modified natural resins, synthetic natural resins, rosins, distillates, oils salvia, balsams, gums, subcomponents thereof and mixtures thereof.
6. A coating for tooth as claimed in clause 4, characterized in that the natural resin system comprises a mixture of colophonium, almacigo and shellac.
7. A tooth coating as claimed in clause 1, characterized in that the natural resin system comprises from about 10% to about 95% by weight of said coating of the teeth.
8. A tooth coating as claimed in clause 7, characterized in that the natural resin system comprises from about 30% to about 60% by weight of said tooth coating.
9. A tooth coating as claimed in clause 1, characterized in that it comprises a film-forming polymer selected from the group consisting of: polyacrylates, polyacrylamides, polyvinyl pyrrolidones, polyvinyl alcohols, polyethylene glycols, polyethylene oxides, polystyrenes, hydroxypropyl methyl celluloses, hydroxypropyl celluloses, hydroxyethyl celluloses, methyl celluloses, carboxymethyl celluloses, copolymers, block copolymers, graft copolymers, crosslinked polymers and combinations thereof.
10. A tooth coating as claimed in clause 1, characterized in that said dye comprises a white dye selected from the group consisting of titanium oxide, aluminum oxide, tin oxide, calcium oxide, magnesium oxide, zinc, polyethylene, polypropylene, ethylene / propylene copolymer, polytetrafluoroethylene, polyhexafluoropropene, and mixtures thereof.
11. A tooth coating as claimed in clause 1, characterized in that said dye comprises a non-white dye selected from the group consisting of copper oxide, chromium oxide, ferric oxide, ultramarine blue, phthalocyanine green, FD &C green No. 1, lacquer, FD &C blue NO. 2 Lacquer, D &C red NO. 30 LACQUER, FD &C YELLOW No. 15 lacquer, FD &C red No. 3, D &C red No. 30, food red No. 17, disodium salt of 6-hydroxy-5-. { (2-methoxy-5-methyl-4-sulfophenyl) azo} -2-naphthalenesulfonic acid, food yellow No. 13, sodium salt of a mixture of mono- and disulfonic acids of quinophthalone or 2- (2-quinolyl) indanedione, FD &C yellow No. 5, FD &C yellow No. 6 , FD &C green No. 3, FD &C blue No. 1, FD &C blue No. 2, and combinations thereof.
12. A coating for tooth as claimed in clause 10, characterized in that said dye comprises titanium oxide.
13. A tooth coating as claimed in clause 1, characterized in that said pearlescent particles are selected from the group consisting of bismuth oxychloride, nacre, mollusk shell, fish scales, pearls, silicate selected from the group consisting of mica. , opal and silica and combinations thereof.
14. A tooth coating as claimed in clause 13, characterized in that said pearlized particles further comprise a metal oxide coating wherein the metal oxide is selected from the group consisting of titanium oxide, iron oxide, aluminum, tin oxide, copper oxide, calcium oxide, magnesium oxide, various oxide, chromium oxide and combinations thereof.
15. A tooth coating as claimed in clause 14, characterized in that said pearlized particles comprise particles of mica titanium.
16. A tooth coating as claimed in clause 1, characterized in that said dye is at a concentration of at least 1% by weight and said pearlized particles are at a concentration of at least about 3% by weight.
17. A tooth coating as claimed in clause 1, characterized in that the coating of the teeth is a tooth coating fluid or a varnish suitable for application to a surface selected from the group consisting of natural hard dental surfaces, surfaces artificial hard teeth, crowns, restorative veneers, partial dentures, compounds and combinations thereof.
18. A tooth coating composition comprising: at least 10% of a natural film-forming resin system comprising at least two natural resins; a colorant; Y an active material
19. A tooth coating as claimed in clause 18, characterized in that said natural resin is selected from the group consisting of dammars, East Indies, copal, acroids, elemi, almacigo, sandarac, colophonium, shellac and mixtures thereof. same.
20. A tooth coating as claimed in clause 18, characterized in that said natural resin is provided in a form selected from the group consisting of: natural unmodified resins, modified natural resins, synthetic natural resins, rosins, distillates, oils salvia, balsams, gums, subcomponents thereof and mixtures thereof.
21. A coating for tooth as claimed in clause 19, characterized in that the natural resin system comprises a mixture of colophonium, almacigo and shellac.
22. A tooth coating as claimed in clause 18, characterized in that said dye comprises a white dye selected from the group consisting of titanium oxide, aluminum oxide, tin oxide, calcium oxide, magnesium oxide, zinc, polyethylene, polypropylene, ethylene / propylene copolymer, polytetrafluoroethylene, polyhexafluoropropene, and mixtures thereof.
23. A tooth coating as claimed in clause 18, characterized in that said pearlized particles are selected from the group consisting of bismuth oxychloride, nacre, mollusk shell, fish scales, pearls, silicate selected from the group consisting of mica. , opal and silica and combinations thereof.
24. A tooth coating as claimed in clause 18, characterized in that said active material is selected from the group consisting of antimicrobials, anti-oxidants, anti-caries agents, anti-plaque agents, anti-calculus agents, bleaching agents, breath fresheners, anti-inflammatories, desensitizing agents, nutrients, pins and mixtures thereof.
25. A composition for coating the tooth comprising: at least 10% of a natural resin system comprising rosin, almacigo and shellac; titanium dioxide; Y mica titanium. E S U M E N A coating for the tooth comprising at least 10% by weight of a natural resin system comprising at least two natural resins; a colorant; pearled particles. Methods for coloring a tooth and methods to avoid or treat conditions for oral care are also provided.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10775706 | 2004-02-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA06008976A true MXPA06008976A (en) | 2007-04-10 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200606474B (en) | Tooth coating compositions and methods | |
CN101005824B (en) | Oral care film | |
ES2319803T3 (en) | ORAL CARE COMPOSITION WITH RETICULATED PEROXIDE POLYMER. | |
US10092482B2 (en) | Oral care compositions with film forming polymers | |
WO2006071677A2 (en) | Instant tooth whitening with silicone resin and silicone adhesive | |
TWI405586B (en) | Compositions and methods for altering the color of teeth | |
JP4527666B2 (en) | Tooth application composition | |
MX2007007629A (en) | Anti-caries oral care composition with xylitol. | |
TW201201854A (en) | Oral care composition | |
US20050069501A1 (en) | Rapid temporary tooth whitening composition | |
CN101316570A (en) | Dentifrice composition | |
US20230000738A1 (en) | Oral Care Compositions and Methods | |
MXPA06008976A (en) | Tooth coating compositions and methods | |
US20180360732A1 (en) | Oral Care Products and Methods | |
TWI819661B (en) | A tooth brightening composition, kit and method of using the same | |
Hosoya et al. | Study of the colors and retention of over-the-counter cosmetic veneers |